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ABSTRACT 
Colorectal cancer represents one of the most common causes of 
morta l ity in the world. A m ajor number of popu lations develop an adenoma by 
the age of 40s . Over the past years, it has become clear that genetic factors 
are of crucial  importance in colorectal tumorigenesis. Fami l ia l  adenomatous 
polyposis (FAP) is responsible of developing numerous colorectal cancers 
cases by causing mutations in the germl ine in adenomatous polyposis col i  
(APC) genes. 
Colon cancer is considered the second most frequent cause of death in 
most of the Western countries . Colonic cancer is common in women and 
rectal in  men. I t  a rise in  adenomatous polyps and is associated with both 
genetic and environmenta l factors that affect the development of the polyp . 
The a im of the present study was to analyze a set of environmental 
and genetic variables that can help in predicting the factors affect the 
formation of colorectal cancer. Additionally, the a im of this study was to 
define the epidemiology of colorectal cancer in AI-Ain city in the United Arab 
E mirates and compare it with regional and international l i teratures . Also, to 
examine the pattern of survival in relation to the initial d iagnostic stage and 
histopathologic grades. The study focus on the comparison between 
patients with colorectal d isease and non-colorectal d isease on the level of 
Ii 
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environmental by studying their l ife style and on the level of genetics by 
screening part of the DNA ( APC gene) for any mutation that cause colorectal 
cancer. 
The study was conducted in the Preventive Medicine Department, Al­
Ain Med ica l District in AI-Ain and Tawam H ospitals .  The study included 65 
patients with colorecta l d isease gone for endoscopy, and 65 control patients 
with non-colorectal d isease, and 7 patients diagnosed with colorectal cancer 
during 2000 year. The retrospective study included a l l  colorecta l cancer 
patients d iagnosed or referred to these two hospitals between January 1 985 
and December 1 998. The retrospective study consisted of 1 1 4 patients with 
colorecta l carcinoma admitted to both hospita ls. 
Although this study is  not intended for general ization of the DNA 
mutation to the whole UAE population, but without any doubt this study would 
be a representative sample of concurrent screening of DNA mutation in the 
commun ity. The first part of the study was epidemiological data presenting 
the l ife style of the patients through out the questionnaire to compare between 
the two groups in  their nutritional habitat, whi le the second part of the study 
focussing on detecting the DNA mutations in the germl ine of the APC gene to 
know the cause of colon cancer formation whether environment or genetical .  
I n  this study three systems o f  primers are used depending o n  the 
frequencies of mutations observed in the APC gene, the set of primers 
designed for system 1 ampl ified 9 1  bp flanking codon 1 309 with incidence of 
1 7% Fami l ia l  Adenomatous Polyposis fami l ies mutation in this reg ion of DNA. 
System 2 ampl ifies DNA fragment of APC gene flanking codon 1 06 1  with 
incidence of approximately 8% mutation , while system 3 ampl ify flanking 
codon 1 546 for mutation approximately 1 . 1 % Famil ial  Adenomatous Polyposis 
family  member. 
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During the last twelve years a total 1 1 4 patients with colorecta l cancer 
were d iagnosed and referred to Tawa m and AI-Ain hospitals in AI-Ain City , Abu 
Dhabi E mi rate, in UAE . Mean annual  incidence was 1 2  patients / year. The 
overa l l  incidence is 6.6 1 1 00,000 patients. There were 77 males (67.5%) and 37 
females (32.5%),  and total of nationa l and Omani  patients were 44 (38.6%) and 
non-UAE national  were 70 (6 1 .4%).  
The mean age at the t ime of diagnosis is 46.6± 1 1 .8 years and with the 
median age of 47 years. The age of highest occurrence was between 4 1 -50 
years and accounted for 34.2%, whi le the lowest accounted for 7.9 % of the 
patients were below the age of 30 years.  
The main presenting symptoms were abdominal pain (29 . 1  %) ,  and cha nge of 
bowel habits ( 1 5 .4%) whi le the predominant sign was recta l bleeding ( 1 7.2%).  
The mean overa l l  survival t ime was 30.89 ± 1 1 .72 months with a range of 
6 and 1 20 months.  The mean survival time was significantly shorter for patient 
aged 40 years or less (p<0. 05). Patients treated by pal l iative resection had a 
highly sign ificant shorter survival than patients who underwent potential ly curative 
surgery (p<0.00 1 ) . The mean survival t ime was significantly related to the lymph 
node status,  peritoneal spread ,  l iver metastasis and Dukes' staging (P<0.001 for 
each factor) . The mean survival time was a lso significa ntly shorter for Patients 
with poorly differentiated tumors than those with wel l  d ifferentiated tumors 
(P<0.01 ) . Althoug h ,  patients with involved proximal ,  dista l and/or lateral surgica l  
v 
margins showed a shorter mean survival t ime, this was of marginal  significance. 
(P<0.05). 
The predictor was significant as shown by the log rank test (p<0.001 for 
lymph node positivity). I n  the Cox proportional haza rds analysis presence of 
lymph nodes and Duke staging only were Sign ificant as shown by the hazard 
ratios . The hazard ratio for positive lymph nodes was 2 .50 (95% Confidence 
interval (CI) 1 .29 - 4 .75) as compared to negative nodes and a hazard ratio of 
0.43 (95% CI 0.28-0. 77) for Dukes stages A and B as compared to Stage C. 
The study showed that the highest occurrence of colorectal cancer is 
about 45-60 years in the study population. The most common presenting 
symptoms was abdominal pain followed by abdominal bleeding. The rectum 
and sigmoid were the most common sites of tumor and our results are 
consistent with studies from U K  and USA. Final ly, the most of the lesions 
were seen in Duke B and C. 
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CHAPTER I 
INTRODUCTION 
1.1 I NTRODUCTI O N  
1 . 1 . 1  What is Cancer? 
Cancer is a heterogenous disease comprising more than 200 types of 
diseases manifested in different tissues in the body and causes many 
different symptoms and i l lnesses (DeVita et al., 1 997). I n  the normal 
conditions, cel ls d ivision is regulated and d ivision of labor is mainted between 
and with in the biochemical pathways leading to cel l  division. There are no net 
accumulations of cel ls in normal tissue because the process of cel l  division 
and replacement is regulated which keeps a dyna mic equi l ibrium between the 
two processes ( Foulds, 1 969) .  This mechanism keeps the body hea lthy. 
Cancer may a rise from one abnormal cel l ,  which loses the regulatory 
mechanisms for prol iferation,  and starts to d ivide randomly to form a mass of 
tissue called growth or tumors (National I nstitutes of health, 1 993) .  
In contrast to normal cel ls ,  cancerous growth losses the regu lation in 
the processes and occur at  the expense of normal tissue arch itecture ( Foulds, 
1 969). Cancer cells a lso have distinctive features in  that they may have lost 
properties that characterize the ce l ls of their tissue of origin ; that is they are 
less differentiated , which i nclude both morpholog ica l and biochemical 
markers. The death of the individual can be caused by obstruction of vita l 
functions and disruption of needed organ structure due to the tumor growth . 
However, there is other factors that causes death such as increased 
susceptibi lity to infection ,  endocrine disturbances, production of toxins, 
psychological problems, and the side effects of therapy (Rosai and Ackerman,  
1 978). 
Mal ignant cel ls have d ifferent characteristics that differentiate them 
from norma l cel ls.  
Mal ignant cel l  usual ly grow more rapidly than normal cel l  and often 
lose cell-cel l  interactions (DeVita et a/. , 1 997). The main features of mal ignant 
tumor is local increase in cel l  number, loss of the normal regular arrangement 
of cel l ,  var iation in cel l  shape and size, i ncrease in nuclear s ize and density of 
sta in ing d ue to the increase of total DNA, an i ncrease in mitotic activity and 
the presence of abnormal mitoses and chromosomes. Mal ignant tumors have 
no wel l defined capsule and the cells grow in d isorganized form.  
Furthermore , the cytology of  cancer cells d iffer from the ones of 
normal cel ls  in which the nucle i d isplay large and i rregular shapes with 
aggregates of chromatin near the membrane in a way to may reflect the 
polyploidy with elevated DNA level .  The nucleol i  may be also larger and more 
numerous ,  this cou ld be related to the greater rate of R NA synthesis. M itoses 
are usual ly more numerous due to the rap id growing cancers. The cytoplasm 
stains more intensely with basophi l ic dyes because of increase of free R NA 
not associated with endoplasmic reticulum, and there may be many vacuoles 
reflecting increased phagocytotic activity (Rosai and Ackerman ,  1 979). 
Tumor growth may infi ltrate surrounding normal tissue with s ingle cel l ,  
cell c lumps or large mu lticel lu lar. The invasion usual ly goes through a th in 
wal ls via lymph and veins but it rarely to infi ltrate through thick arter ies and 
arterioles because of the barrier created by elastic tissue which is resistant to 
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the invasion.  The invasion mechanism goes through three process: 1 )  
release of enzymatic or lytic factors which is characterized by recreation 
behavior of lyt ic factor, 2) development of pressure through cellu lar 
proliferation , 3) and cel lular movement from its natura l context \'Nood and 
Straul i ,  1 973). 
1 . 1 .2 M ultistage Carcinogenesis: 
The formation of tumor is not a result of d i rect and immediate exposure 
to carcinogen but it goes through series of changes to form a tumor. 
Carcinogens or promoting agents do not themselves produce tumors but as a 
result of damage in the genetiC material .  (Cairns , 1 975) 
Carcinogenesis can be divided into four stages: tumor in itiation , tumor 
promotion ,  mal ignant conversion and tumor progression. Tumor i nitiation 
occurs as a result of i rreversible genetic damage, whereas tumor promotion 
comprises the selective clonal expansion of initiated cells, following by 
production of a large population of cells that are at risk of further genetic 
changes (Figure 1 ) . The process of transfonning the preneoplastic cell into 
one that expresses the mal ignant phenotype is called malignant conversion 
(Holland et at., 1 993).  
3 
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Figure 1 . Schematic model of multistep carcinogenesis. "Genetic 
change" refers to such events as the activation of proto­
oncogenes or drug resistance genes or the inactivation of tumor 
suppressor genes (Haskell, 1995 ) .  
1 .2 CELL BIOLOGY: 
Cell is the basic un i t  of  l iving organisms. Single or complex containing 
all characteristics to perform its function in growth,  reproduction , response to 
outside stimuli, and movement. 
Cells are surrounded by plasma membrane to organize su bstance 
passing into and out of the cell . The protoplasm of the cell is divided into 
distinct reg ions, the nucleus and the cytoplasm, by the nuclear envelope, 
which consists of two concentric membranes crowded with a large number of 
pore complexes serve as transport channels between the nucleus and the 
cytoplasm. 
In  the nucleus ,  most of the space inside is occupied by chromatin 
which are irregular coiled fibers contain ing the DNA of the cell . Su spended 
with the chromatin of the nucleus are one or more nucleol i .  The nucleolar 
material is so densely packed with no mem brane separating the nucleolus 
from the surrounding chromatin, the major function of nucleolus is to 
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synthesize ribosoma l R NA and assemble this RNA with ribosoma l protein into 
ribosomal subunits , which combine i n  two in  the cytoplasm to make finished 
ribosomes. 
The portion of the cel l  outs ide the nucleus is the cytoplam. and the 
cytoplasm contains a variety of membra ne-bound organelles. M itochondria 
are constructed from two separate membrane systems, the outer membrane 
is smooth and continuous but the inner membrane contains many folds ca lled 
cristae, carrying necessary enzymes for oxidization reaction to release energy 
for the cel lu lar  activities. 
The organel le with d iameter of a bout 25-35 nm is  the ribosome. 
R ibosmes may be either freely suspended in  clusters or attached to the 
surface of endoplasmic reticu lum (ER) .  Both ribosomes and ER co-operate to 
synthesize and transport proteins.  Proteins synthesized on the ribosomes 
penetrate into membranes of the E R ,  forming a part of the membrane 
structure,  or into the enclosed ER channels.  The channels enclosing the 
proteins eventual ly bud off, forming spherical membrane bound sacs of 
protein that have various fates in the cel l .  Some remain in the cytoplasm as 
storage vesicles. or undergo further processing in the Golgi apparatus. 
Golgi  apparatus is  a flattened sac where the proteins a re modified by 
the attachment of carbohydrate. l ip id or other groups. these modified proteins 
may be stored in the cytoplasm for cel lu lar use or may be secreted to the 
exterior (Alberts et a l . .  1 989) .  
ER is d ivided into two systems. rough ER with ribosomes attachment is  
responsible for protein synthesis. and smooth ER which a re free from 
ribosomes and is involved with the in it ial breakdown of fats to re lease energy 
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from cellular activities. A membrance organelle conta in ing a storage of 
enzyemes is lysosome, these enzymes are required for intracel lular digestion 
and also to prevent the cell  from outside attachment. 
The motil ity of the cel l ,  wh ich plays an i mportant role in cancer, is due 
to cytoskeleton , which is composed of a network of protein fi laments, 
microtubules and microfilaments. M ictotubules are constructed from polymers 
of protein molecules cal led tubul in ,  cyl inders of about 20-25 nm in  diameter, 
whi le microfi laments are fibrous and of much finer dimensions, about 5 nm in 
d iameter, consisting of long polymers of protein called actin ,  associated with 
another protein cal led myosin .  Microtubules and microfi laments, both 
produce the force for cell movement by an active sl id ing mechanism, and this 
force is dependent on chemical bonds that are a l temately made and broken 
between adjacent microtubules or microfi laments . 
Microtubules and microfi laments also form supportive netwoks in  the 
cytoplasm in addition to other supportive classes cal led intermediate filaments 
(diameters of a bout 1 0  nm) built up from various nonmoti le structural 
proteins, keratin , desmin and vimentin (Wolfe, 198 1 ) .  
1 .3 The Molecular Biology of M acromolecule: 
There are major biolog ica l  classes in the cell , l ip ids,  carbohydrates 
proteins and nucleic acids.  
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1 .3. 1 Lipids: 
Lipids are a heterogenous group of biologica l  molecules that dissolve 
in nonpolar solvents . This solubility refl ects the presence of a predominance 
of nonpolar groups in l ipid molecu les , giving them a hydrophobic character 
which is very important in cell structure. Lipids are a lso important as an 
energy source and are stored in quantity in many cell types for this purpose. 
The three common types of l ip ids a re: neutral l ip ids, phospholipids, and 
steroids. 
1 .3.2 Carbohydrates: 
Carbohydrates are important as fuel and structural molecules in cell. 
Carbohydrates a re usually stored as starches in the cell , which are long chain 
repeat molecules l inked together from the ends. Carbohydrate units may l ink 
with l ip ids to form g lycol ipids, and with proteins to form glycoproteins. These 
complexes are found at cel l  surfaces as a recognition group for the cel l .  
1.3.3 Proteins: 
Proteins are long, complex molecu les that work as structural molecules 
to provide the frame work of cells ;  as enzymes and as molecu les that provide 
movement to cell s  and cell parts . Protein also works as secreted substance 
such as hormones and antibodies. Protein consists of unbranched chain of 
subunits ca l led amino acids, and there a re only 20 different amino acids used 
by cel ls to make d ifferent proteins. The tota l number of a mino acids l inked to 
form protein chains range from 50-50 ,000. 
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1 .3.4 Nucleic acids: 
There are two nucleic ac ids, deoxyribonucleic acid (DNA) and 
ribonucleic acid  ( R NA). They are considered as the informational molecules 
for al l l iv ing organisms. They are polymers conSisting of nucleotides. The 
sequence of nucleotides in  nucleic acid molecules forms a code that stores 
and transmits the information required for cell growth and reproduction. Many 
nucleotides or molecules bui l t  on nuc leotides transport chemical energy in 
form of phosphate groups or electrons from one reaction system to another, 
others carry metabolites such as acetyl g roups between reactions. 
N uc leotides consist of n itrogen base, five carbon sugar, and phosphate 
groups l inked together by covalent bonds. The n itrogenous bases are d ivided 
into pyri midines and purines,  ring shape molecules conta in ing carbon and 
nitrogen atoms. The pyri midine bases a re uraci l  (U) ,  thymine (T), and 
cytosine (C), whi le the two common purine bases are adenine (A) and 
guanine (G). These n itrogenous bases are l inked in nucleotides to one of 
two five carbon sugars (pentoses), either ribose or deoxyribose. The two 
sugars d iffer only in the chemical  g roup bound to their carbon rings at the 3'­
carbon.  R ibose has an -OH group at th is position and deoxyribose a single 
hydrogen. The phosphate group is l inked to the ribose or deoxyribose unit at 
it's 5'-carbon (Wolfe, 1 98 1 ) .  
1 .4 Colon Cancer: 
In the Un i ted States, colorectal carc inoma is the second most frequent 
cause of cancer deaths , ran king th ird behind lung and prostate cancer in  men 
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and third behind lung and breast ca ncer in women (Landis et aI., 1 999). A 
bout 5% of the US population develops this cancer during their l ifetime. In 
1 999, there are an estimated 1 29,400 diagnosed patients with this cancer and 
56,600 deaths (American Cancer Society, 1 999).  About 80% of patients with 
colorectal cancer have sporadic d isease with no apparent evidence of having 
inherited the disorder. The remaining 20% of patients have some form of 
inherited susceptibi l ity (Burt and Petesrson, 1 996) and (Herrera, 1 990) .  
1 .4. 1 Epidemiology:  
The etiology of  colorectal cancer is influenced in  part by  economic 
development and socia l  strata. It is also evident that there is marked 
intemational geographic variation in the incidence of colon cancer (Seg i ,  
1 984) .  In countries with multiple registries o r  in  which there are mult iple 
ethnic groups, selected incidence data are included. Subdivision of colon and 
rectal cancer  is not always possible because of the variation in classification 
and reporting that exist between countries. However, the highest incidence of 
colorectal cancer is found in the most advanced industria l ized societies 
except Japan ,  whereas the lowest incidence occurs in developing countries. 
The incidence rate varies from as  low as 1 .9 cases per 1 00,000 population in 
Senegal (WatertlOuse et a/. , 1 982) to as high as 35.8 cases per 1 00,000 
population in Connecticut (Schootenfeld and Winawar, 1 982). The extent of 
the d ifference in  incidence between the h ighest and the lowest could be 
interpreted as representing maximal potentia l  for prevention . 
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Males general ly have a higher incidence of colo rectal cancer than 
females. In Hawai i ,  the Japanese and Chinese had the highest ratios 1 .8 and 
1 .6 respectively. The lowest was seen among the Hispan ics in New Mexico, 
where the ratio was 0 .9 (Waterhouse et a/., 1 982) .  
An increased incidence has been noted main ly in Austral ia ,  New 
Zealand ,  North Ameri ca ,  and portions of Western Europe, whereas a 
decreased i ncidence has been reported in I nd ia ,  Latin America , Southern 
Europe, and in Japan, a lthough the rate there is rising as the d iet becomes 
westernized.  Within these countries , there is also considerable regional and 
racial variation .  I n  Japan ,  there are distinct regional variations in colon 
cancer, but not rectal cancer (Taj ima et a/., 1 985).  The h ighest death rates 
among males are found in urban centers; l ikewise, the highest female death 
rates are found in urban centers, mainly in Northern Japan (Waterhouse et aI., 
1 982) .  
1.4.2 Colon Cancer Development: 
It is a pathologic outgrowth of a normal developing colonic crypt. Crypt 
epithel ia l  cells undergo a remarkable natural h istory. Born as daughters of 
stem cells at the bottom of the crypt, which d ifferentiate into mature 
colonocytes with in 2-4 days as they migrate up the side of the crypt At the 
end of d ifferentiation, the cel ls are sloughed from the colonic surface and 
undergo apoptosis (Jen et a/., 1 994). 
The polyp have foci that show dysplasia of crypt cel ls ,  these foci are 
local ized , d istinct metaplastic regions usual ly involve 1 0  or more crypts. The 
1 0  
focal nature of the dysplastic crypts would suggest either clonal expansion of 
cell forman in itial metaplastic crypt, or by the effect of a morphogen generated 
by a central crypt (Figure 2 and 3). 
Polyps may occur singly or as multiple tumors throughout the 
colorectum, and more than one histological type may occur in  the same 
individual (Morson et a/. ,  1 990) 
Most polyps are clinical ly si lent. but surface trauma. congestion. and 
erosion may result in occu lt or overt bleeding (Foutch et a/ .. 1 988; Waldock et 
a/. . 1 989). If particularly large. polyps may be responsible for abdominal 
d iscomfort or pain secondary to obstruction. or prolapse. Additional ly. 
electrolyte and protein loss may ensue from polyps with extensive surface 
areas; th is occasional ly occurs in patients with either vil lous tumors or the 
polyposis syndromes (Gerharz et a/.. 1 987). However. the greatest concem is 
the potential for benign adenomatous polyps to undergo malignant changes. 
Figure 2 .  carcinomatous polyp with an 
irregular, friable surface. Carcinomatous 
Invasion may be suspected when the 
surface appears hard, irregular, or 
ulcerated, But pathologic examination is 
the final arbiter. (Ahlgren and 
Macdonald, 1992) 
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Figure 3. Removal of a small polyp by 
means of hot biopsy forceps. This 
procedure is suitable for diminutive 
polyps less than 5 mm in diameter, but 
may be dangerous for larger polyps 
owing to the risk of a full thickness burn. 
(Ahlgren and Macdonald, 1992) 
1 .4.3 The spread of colorectal cancer: 
Dukes studied the spread of recta l cancer in 1 932 . He noted that 
cancers were in it ial ly confined to the wal l  of the bowel .  He suggested that the 
tumors tended to grow in a transverse rather than longitudinal fashion. The 
rate of growth around the circumference was estimated to be 25% in 6 
months (Dukes, 1 932). Black and Waugh noted the same g rowth pattern in 
that the cancer tends to be circumferentia l  rather than longitudinal in growth 
pattern (Black and Waugh,  1948). Virtual ly al l  studies have shown that 
curable carcinoma of the colorectum does not spread d istally within the wal l .  
I n  1954, Grinnell and Quer and associates in 1953, performed serial sections 
of the rectal wall distal to colorectal cancers. They did not find tumor cel ls 1 
cm d istal to the cancer intramural ly unless metastases had heavily infi ltrated 
the lymphatiC system (Grinnel l, 1954; Quer, 1953). 
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Cancer may grow local ly  into adjacent peri rectal fat, or the muscular 
side wal ls of the pelvis, prostate, vagina, bladder, ureters, duodenum, or 
pancreas. Anteriorly, the tumor may attach itself to a loop of bowel or the 
dome of the bladder. Someti mes, the cancer is well confined and is the only 
viable focus of cancer in  the body; thus, this mass of cancer, binding adjacent 
organs together, is better excised as a un it, the so-ca lled 'en bloc' resection 
(Morson and Dawson, 1 972).  
1 .4.4 Lymphatic Spread : 
Carcinoma general ly metastasizes via lymphatics centra l ly into the 
body. Cure is possible if the adjacent lymph nodes are removed with the 
cancer as a unit .  Gabrie l  and co-workers delineated the process of lymphatic 
spread (Gabrie l  ef a/., 1 935) .  They were able to show that reg ional lymph 
nodes were first to be affected, beginn ing with the paracolic nodes. The 
nodes affected were in a d i rect l ine from the cancer to the central location 
along the lymphatics, which para l lel the nearest major arteries and veins. The 
size of lymph nodes has not been a good indicator as to the presence of 
metastases. 
Metastases may spread lateral ly into the internal i l iac lymph nodes; 
theoretically, this site should be included in an en bloc resection .  Steams and 
Deddish found a 9% incidence of lateral  pelvic nodes in 1 22 operated patients 
(Steams and Deddish, 1 959) . 
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1 .4.5 Hematogenous Spread : 
Tumor cel ls may be carried by venous blood to distant organs, with the 
liver being the most common site. In 1 965, Salsbury and col leagues reported 
a high incidence of mal ignant cel ls in blood from the common i l iac veins 
(Salsbury et al. , 1 965).  They bel ieved that retrograde flow occurred after 
l igation of the inferior mesenteric vessels. However, free malignant cel ls were 
identified by Cole and associates in the venous blood prior to manual 
manipulation (Cole et al. , 1 954). Griffiths and co-workers found that 
Circu lating mal ignant cells were present in 28% of their patients during the 
induction of anesthesia and 50% of their patients during laparotomy (Griffiths 
et al. , 1 973) .  
1 .4.6 Implantation :  
Approximately 1 0% of patients with colon carcinoma develop peritoneal 
implants (Gol igher et aI. , 1 95 1 ) .  I ntraperitoneal tumor cells may implant on 
any peritoneal surface, with or without other lymphatiC or vascular spread 
(Figure 4). 
1 4  
-.­
v­
..• ..,.. 
. :��. ... � �.: 
Prn' • ..tr·.1.r1 
.1" < C;T'!.CfI� 
,., ·r�·I"� 
.::�:.;.' ' .... . I ' "  . ... . C r .'r .' " ,1' 1 
;'u t:C"! 
QI..:t.'rrc\,," t\(' 
c) I '  
.'.-� l' 
.... .. ;!' : .. � 
s· ",.z., .. � .. 
$:'''::..Ift.: ',;).-: 
l�", .. "' ..Jr 
Cr.: t ... • .�. ,-: 
l ., : ... 0.;)::' ( . .. S< "f,",� .. ::. 
Figure 4. Classification of microscopic features of colorectal cancer (Moossa et 
aI., 1991). 
1.5 Staging of Colorectal Carcinoma: 
The usual staging of colorectal cancer is based upon examination of 
the specimen after surg ical removal . This staging gives clues to the 
prognosis for the patient. 
The classification include the fol lowing categories: stage A: tumor 
confined to the bowel wal l ,  stage B :  tumor extending to perirectal tissue, stage 
C 1 :  only regional nodes a re involved but upward spread did not reach the 
point of l igature of blood vessels, and stage C2 : cases in  which nodes at the 
point of l igature were involved ( Du kes, 1 929). 
The Original  stage A refers to cancer growth l imited to the wal l  of the 
rectum. The B class involves extension of cancer  to the extra rectal tissues, 
but no involvement of regional lymph nodes. The C stage represents 
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metastases to regional lymph nodes. Dukes himself mod ified the 
dassification after 1 932 (Gabriel et at., 1 935) .  
I n  1 949, Kirklin and col leagues and Astler and Coller in 1 954 divided 
the 8 and C categories into two subsets designated by the number 1 and 2 .  
Those who are in 810r C1 had cancer confined to the bowel wal l ,  whereas 
those with 82 or C2 had tumors that had completely penetrated through the 
bowel wa l l  (Figure 5) 
The TNM system was introduced in 1 954 and was used initial ly by the 
Union Intemationale Contre Ie Cancer (U ICC) (Denoix, 1 954). The TNM 
system defines more specifical ly than the other dassifications where the 
tumor has extended. Subsequently, a version of the TNM classification was 
adopted by the American J oint Committee on Cancer (AJCC) (American Joint 
Committee on Cancer, 1 987) .  
Later on,  there have been some new and very extensive classifications 
developed, such as the Austral ian and American clin icopatholog ica l staging 
systems (Davis and Newland, 1 983; Fielding, 1 988) .  
Tools are currently being developed that may further improve 
pretreatment staging.  Ultrasonographic devices may be appl ied to 
colonoscopes, extending our abi l ity to look at bowel wal l  penetration.  
Radioactive monoclonal antibodies that are tumor-specific are being tested for 
preoperative imaging and therapy. The detennination of DNA content by flow 
cytometry in a simple biopsy specimen may predict the aggressiveness of a 
cancer. 
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1.6 RISK FACTORS: 
The more we learn about what causes cancer, the more l i kely we are 
to find way to prevent it. Cancer develops as a result  of many complex 
factors related to lifestyle, environment, and heredity. 
CarCinogenesis can be initiated by a variety of events or agents. 
Exposure to radiation can init iate colorectal carcinogenesis (Sandler, 1 983). 
Chemica l  carcinogens may initiate the process. Candidate chemicals include 
various Porte in  metabolites; ammonia,  volati le phenols, tryptophan 
(Cummings, 1 979). 
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A large number of risk factors for colorectal cancer have been 
identified. Diseases such as chronic inflammatory diseases (u lcerative col itis , 
Crohn d isease, or Schistosomiasis) are involved in developing large bowel 
carcinoma. The history of colorectal neoplasia increase the risk for the other 
fami ly members especial ly the first degree relatives. A positive family history 
can range from rare autosomal dominant syndromes with high frequencies of 
colorecta l cancer. The younger the age of the fami ly member with colorecta l 
neoplasia, the greater the statistical risk  for the first degree relative (Kinzler 
and Vogelstein, 1996). 
Lifestyle factors play a role in the genesis of colorectal neoplasia as 
evidenced by numerous epidemiolog ical studies (Winawer et al., 1997) .  
E mphasis has been d i rected at d ietary factors such as high fat intake; low 
consumption of fiber, frui ts and vegetables, calcium, and selenium; tobacco 
use; and sedentary l ife style. 
1 .6 . 1 Environmental Factors: 
1 .6. 1 . 1 Dietary Fiber: 
The incidence of colorecta l cancer has geographical variations 
due to different d iet between the countries . Low fiber d iet was suggested 
as the causative factor (Jones, 1999). The h igher the fiber content, the 
lower incidence of colon cancer due to the rapid transit time which reduce 
the time of carcinogens or their precursors contacting in the clonic mucosa 
(Burkitt, 1972) .  However, there is l i ttle evidence that a decreased transit 
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t ime reduces bacteria l  action on colon content (VVynder, 1 975) and studies 
of population with widely varying incidence of colon cancer show no 
differences in bowel transit time (Glober, 1 977).  The differences in d iet 
between d ifferent ethnic groups make it d ifficult to know which 
components can be considered responsible. 
The paradox i l lustrated by Eskimos, who have low fiber and high 
fat d iet, have a very low incidence of large bowel cancer. However, 
d ietary factors play parts between black Africans who adopt a Western 
diet, it was found out that their incidences of colorecta l tumors 
progressively increases. 
Fiber has been considerd as a protective agent because it 
decreases bowel transit  t ime, increases stool bu lk, and binds 
intraluminal carcinogens which reduce the contact t ime of carcinogen 
potential with mucosa (Jones, 1 999). 
There is  a hypothesis derived from international analysis of 
cancer frequency on migrants. The studies show high incidence of 
various cancers in migrant who leave their homeland to l ive in new 
country with d ifferent l ifestyle and environmental factors. The 
differences in  rates between homeland and new country among 
identical ethnic groups leaves no doubt that new influencing factors 
were introduced with migration. Descendants of Japanese immigrants 
to the United States develop the cancer incidence patterns typica l  of 
other Americans with in one generation. Persons of Scandinavian and 
Celtic descent have low rates of skin cancer when l iving in  Northern 
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Europe, but persons with the same background who l ive in tropical 
areas have high skin cancer rate due to the exposure to sun light 
(Ames and Gold, 1 99 1 ) . 
1.6. 1 .2 Alteration in Bowel Microflora :  
The nature of the bacterial flora of the bowel ca n  b e  determined 
by the diet and that diet a lso provides a substrate for any bacteria 
induce to change of normal bowel contents to carcinogens. Since 
people l iving in areas with high incidences of colon cancer have high 
fecal concentrations of bi le acids, the capacity of the bacteria to 
desaturate the bi le acid nucleus might be an important factor in 
carcinogenesis (H i l l ,  1 964) .  
The epidemiological studies showed that bacteria and higher 
quantities of bi le salts have been found in the feces from a cancer 
prone population compared with those from a low risk population 
(Jones, 1 999) and (Reddy, 1 973) .  
1 .6. 1 .3 Alcohol: 
Alcoholic behavior is associated with cancer of the l iver 
and of the esophagus, especia l ly i n  some parts of the world .  However, 
it does not seem that ethanol itself is carcinogenic which leads to 
conclusion that some of the hund reds of compounds that have been 
identified in alcoholic beverages are responsible for the carcinogenic 
effects (Com, 1 993) .  
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1 .6. 1 .4 Water: 
Carcinogenic pesticides run off fields into streams, rivers, 
and lakes and concentrated through the food cha in. The contamination 
of water with carcinogens is most serious when the water is used for 
subsequent human consumption. All of the agricultural and industrial  
wastes that enter the air  a lso find their way into water, occasional ly 
large bodies of water where their carcinogenic properties are red uced 
by d i lution (Com, 1 993) .  
1 .6. 1 .5 Age: 
The incidence of colon cancer increases after the age of 40, 
and rises each decade thereafter by a factor of about two until it 
peaks at age 75 years .  This may result from the action of 
carcinogens on colon ic cells over an increasing period. The risk i s  
about the same for men and women over 40 years of  age. When 
colon cancer occur before the age of 40 years,  it usual ly does so in 
conjunction with some of the other risk factors, especial ly famil ial 
ones (Berg, 1 973). 
1 .6. 1 .6 Hormonal factor: 
The development of cancer in a species is influenced by a wide 
variety of changes in the internal and external environment of the host. 
The degree of effect on the development of neoplasms may be 
correlated roughly with the degree of extent of such changes. The 
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aspects of internal environment that have been stud ies most are 
hormonal status and nutrition. 
Hormonal imbalance in  mice leads to the appearance of at least 
five types of tumors in tissues especial ly dependent on hormonal 
secretions in their physiology (Gardner, 1 953). 
Excessive estrogenic stimulation, endogenously or exogenously 
suppl ied leads to the development of testicular, p itu itary, or uterine 
tumors in  appropriate stra ins of  animals .  The age of  the animal and 
the t ime of exposure to a carcinogen profoundly influence the 
carc inogenic reaction (Tannebaum and Si lverstone, 1 953).  
1.6.1.7 Occupational Exposure: 
Workers in certa in occupations exposured to carcinogens 
developing certain cancers . Early example was the observation of 
bladder cancer in workers in dye factories as a result of exposure to 
aromatic amines. 
Rad iation has been identified as carCinogenic for a long time, 
fo l lowing the early discovery that x-rays cause several types of cancer 
(e . g .  s kin and thyroid) .  Excessive exposure to sunl ight has been l inked 
to skin  cancer. Early workers who painted watch and clock dia ls with 
lu minous paint contain ing radium salts frequently l icked the brush and 
were early victims of cancer especial ly of the bone , caused by the 
a lpha particles emitted by the rad ium.  Another physical agent, 
asbestos, has been long associated with lung cancer (Corn , 1 993). 
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1 .6. 1 .8 Chemical Carcinogenesis: 
Many carcinogens are recognized as carcinogenic in human as 
result of industrial ,  medica l  and societal exposures (8Iaga, 1 980) .  I t  
appears that additiona l chemica l  carcinogens from natural and 
synthetic origin wi l l  be identified as cancer factors. 
The theory that explained the chemical carcinogenesis was 
proposed by Mi l ler and Mi l ler ( 1 976). They stated that all chemical 
carcinogens that are not electrophi l ic reactants must be converted 
metabol ica l ly  i nto a chemical ly reactive electrophi l ic form that reacts 
with some critical nucleophi l ic sites in macromolecules to initiate the 
carcinogenic process. 
The ubiqu itous polycyclic aromatic hydrocarbon carcinogens are 
metabolized by the microsomal mixed-function oxidase system of 
target tissues to a variety of metabolites. The major pathway of 
activation of benzo(a) pyrene (BP) leads to the formation of dihydrodiol 
expoxide of BP which interacts predominantly with the 2-amino of 
guanine of DNA. The dihydrodiol-expoxide of BP appears to be the 
major ulti mate electrophi l ic, mutagenic, and carcinogenic metabol ite of 
BP (Jerina et al. , 1 976) 
Ani l ine, 2-naphthylamine, benzidine, p-d imethyla mino-
azobenzene and N-2-fluoreny lacetamide (2-FAA) are examples of 
aromatic amine carcinogens,  these groups possess reactive primary or 
secondary amine groups which play an active role in determining the 
carcinogenicity of the compounds. The 2-FAA metabolic activation 
involves a N-hyd roxylation (proximate carcinogen) fol lowed by 
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esterification to an u ltimate reactive carcinogen that can react with 
nucleic acids or proteins (Mi l ler and Mi l ler, 1 976) .  
An i mportant class of  carcinogenic compounds are ni trosamines 
and n itrosamide, where nitrosamines require metabolic activation by 
target t issue microsomal mixed-function oxidases. Unl ike the previous 
aromatic hydrocarbons, nitrosamines needs only the first activation 
step to forms the intermediate hydroxylate which generate a reactive 
carbonium characterzed by the abi l ity to rapidly alkylate target 
macromolecules in the cel l .  However, nitrosamides have inherent 
chemica l instabi l ity in aqueous solution , that is why it's not in need of 
metabol ic activation. N itrosamides also decom pose nonenzymatical ly 
to produce the same class of reactive electrophi les as the nitrosamines 
(M il ler and Mi l ler, 1 976) .  
1 .6.1 .9 Viral Carcinogenesis: 
Many researches are d iscovered the viral influence on tumor 
formation. The viral oncogenesis requires several steps, first, the 
in itiation stage where the viral DNA is integrated into the host genome 
to stably transform the cel l ,  where these transformed cel ls express one 
or more vira l  gene products that immorta l ize the cel l .  Lastly other 
transforming viral genes requ ired for expression of the fu l l  neoplastic 
phenotype. 
Tumor from th is type contain DNA from "oncodnavi ruses" or 
R NA-containing retroviruses. Most of the DNA viruses contain 
oncogenic properties (Table 1 )  whereas only one (containing B-, C- , 
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and D- type) of the n ine groups of R NA viruses has been shown to be 
oncogenic. 
Retroviruses can induce tumors with in 1 -4 weeks and cause 
mu ltiple tumors where the oncogenes can transfectly by i ntroduction of 
the cloned gene by DNA transfection ,  and this is the acute tumorigenic 
retroviruses. However the non-acute one induces only s ingle tumors 
within 4- 1 2  months after the infection, and the vira l  genome may be 
integrated into the DNA of the host as a provirus and transmitted l ike a 
cel lu lar gene through somatic or germ ce l ls. 
The main effects of viral transformation are :  losing cel lu lar 
contact inhibition of growth disturbance of cell morphology and 
transformed cel ls may p i le up to form d istinct foci invitro. The injection 
of vira l ly transformed cel ls into syngeneic animals often leads to tumor 
formation . A lot of changes occur often noted in differentiation,  
immunogenicity and cell adhesion d uring viral oncogenesis , also some 
transformed cells become more immunogenic as a result of viral 
antigens, other viral gene products can down-regulate host 
h istocompatib i l i ty antigens, leading to evasion of immue destruction. 
Chromosomal abnormalit ies are noted rearrangements and 
development of aneuploidy in  some viral ly transformed cel ls (Hayward , 
1 988) . 
Thirty d ifferent serotypes of adenoviruses have been identified 
in humans. Class A vi ruses especia l ly type 1 2 , 1 8  and 31 are highly 
oncogenic when introduced into newborn rodents. Other adenovirus 
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classes can transform rodent cell invitro and produce tumors under 
certain factors (Ruley, 1 983). 
Table1. Effect of viral transformation on host cells. (Moossa et al. , 1991) 
Cel lular property 
I ntercellu lar communication 
Cell growth 
Cel lular ad hesion 
Immunogenicity 
Karyotype 
Differentiation 
1 .6.2 Genetic Factors: 
Viral  a lteration 
Decreased, resulta nt loss of contact 
Inhibition . 
unregulated, often increased 
Decreased with potential for metastasis 
Increased with novel tumor antigen s, or 
decreased with lowered h istocompatibi l ity 
antigen s. 
Chromosomal t ranslocation s, rearrangements, 
development of aneuploidy. 
Disturbed , often blocked . 
To turn a normal cell into a cancer cel l  many steps are needed, and 
the mutational change is the most i mportant changes in the somatic and 
germl ine level (Hal land et aI., 1 993).  Many agents produce mutations in 
DNA, altering the tautomeric form of a base during DNA repl ication which may 
be of influence in the transcription of DNA into R NA. 
I n  some cases the mutations may be si lent with no effect whi le in other 
occur within a codon leading to an alteration of amino acid structure which 
can be harmful especial ly if it's not repa ired (Wil lis and Lindahl ,  1 987). 
Chromosomal deletions in human tumors presented as an evidence for 
the deletion of a tumor suppressor genes regions. Tumor suppressor genes 
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are responsible for reg ulated normal growth which indirectly suppress 
neoplastic prol iferation (Horwich, 1 995) .  
1.6.2. 1 Genes Associated with Colon Cancer: 
The responsibi l ity of developing hundreds of colorectal adenomas in 
adults are caused by famil ial adenomatous polyposis (FAP) (Bussey, 1 965) 
Recent studies d iscovered that FAP is caused by germline mutations of 
the adenomatous polyposis coli (APC) gene located on the long arm of 
chromosome 5 in band q2 1 (N ishisho et a/. , 1 99 1 ; Kinzler et a/. ,  1 99 1 ; and 
Groden et a/. ,  1 99 1 ) . 
The APC gene contains 1 5  exons responsible for producing 2843 
amino acids with molecular weight of about 300,000 da ltons (Joslyn et a/. ,  
1 99 1 ; M iyoshi et aI. , 1 992). Mutations l ike framesh ift and point mutation on 
APC leads to truncation of the gene product, especial ly the deletion of 5-base 
pair (-AAAAG) wh ich result in a frameshift mutation at codon 1 309 in about 
20% of reported literature cases (Nagase et a/. , 1 992;  Utsunomiya et a/. ,  
1 990). Patients with FAP are at increased risk for intestinal cancer, especial ly 
duodenal and periampul lary carcinomas (Offerhaus et a I . ,  1 992) and for recta l 
in those with subtotal colectomy (Boland et aI . , 1 989).  Extraintestinal cancers 
reported in association with FAP include tumors of the thyroid g land , adrenal 
g land,  b i l iary tree, and pancreas (Burt, 1 99 1 ; Haggitt and Reid, 1 986). 
Francis et a/. , ( 1 994) studyed the variable phenotypes of 74 patients 
with fami l ia l  adenomatous polyposis from unrelated fami lies with an identical 
(-AAAAG) deletion at codon 1 309 of APC gene, and they found out that 1 6  
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patients from 9 fami l ies have sigmoid colon polyp density varied from 3.8 to 
1 3. 1 1  cm2 , and mean polyp diameter ranged from 1 .4+ or - 0. 1 to 2 .7  + or -
0. 1 mm. Colonic adenomas distribute differently, with spreading polYPosis in 
6 patients, but polyp sparing in the more proximal  colon in  6 others .  
The mutant DNA can be found in somatic and germl ine,  this APC gene 
mutations include a mixture of predominantly small deletion and a variety of 
single base pair changes giving rise to nonsense mutations (Bodmer 1 994a;  
Beroud and Soussi 1 996). 
A h igh proportion of the changes occur at CG positions, well known to 
be frequently methylated and therefore subject to spontaneous deamination 
and relatively high mutation rates (Sved and Bird ,  1 990). The only way that 
such mutations can lead to a stop codon is if they occur from an argin ine 
codon , and that is why many nonsense mutations observed in a variety of 
different situations are arginine to stop codon changes. The ratio of G :C to 
T:A transversions to other transversions in carcinomas and adenomas is 
significantly d ifferent from that in the germline ,  the percentage being between 
1 0- 1 5% of the total observed set of somatic mutations. This indicates that 
there is no major role for external mutagens in the geneSis of colorectal 
cancer, in which no G:A transversions are seen in colorectal cancer, however, 
in lung cancer 40% of a l l  changes observed as expected from the mutagenic 
effects of the hydrocarbons in cigarette smoke (Harris ,  1 993). 
The function of APC gene came from the observation that it has a 
series of motifs that correspond to B-catenin binding sites, and that through it 
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interacts functional ly with the cell-cel l  adherence molecule E-cadherin 
(Rubinfeld et a/. , 1 993; Su et a/. ,  1 993). Further studies show that APC also 
binds the GSK protein and plays a control l ing role in  the signal ing pathway 
mediated by B-cateni n  when it is not degraded and enters the nucleus 
(Rubinfeld et a/. , 1 996; Peifer, 1 996;  l I yas  and Tomlinson et aI. , 1 997). 
Several sequence motifs characterize APC : "coi led coi l "  motifs in the 
N H2-tenninal  region al low APC to ol igodimerize (Su et a/. ,  1 993a; Joslyn et 
a/. , 1 993) ;  the B-catenin binding and downregulating repeats al low 
interactions among APC and B-catenin,  a protein known to associate with E­
cadherin  in the fonnation of ep ithel ial  cel l-cel l  contacts, and to participate i n  
the Wnt signal transduction pathway (Rubinfeld e t  a/. , 1 993, 1 997; Su e t  a/. , 
1 993b; Kori nek et a/. , 1 997; Morin et a/. ,  1 997) ;  the conduction binding 
repeats al low conduction and axin to induce APC-mediated B-catenin 
degradation (Behrens et a/. , 1 998;  Hart et a/. , 1 998); and a COOH-tenninal 
basic amino acid cluster thought to be responsible for the bind ing of APC to 
microtubules (Munemitsu et a/. , 1 994; Smith et a/. ,  1 994) .  
APC mutations leads to early termination codon between amino acid 
600 and 1 ,600 usual ly result in  stable truncated APC polypeptides in  several 
FAP phenotypes characterized by a h igh number of polyps (Smith et aI . , 
1 993; Gismondi et a/. , 1 998). Nonsense and frameshift mutations upstream 
of codon 200 and downstream of codon 1,600 or located in alternatively 
spl iced exons of APC have been reported to result in  attenuated 
adenomatous polyposis coli (AAPC) (Leppert et a/. , 1 990; Spirio et a/. , 1 993; 
Van der Luijt et aI. , 1 995 , 1 996; Samowitz et a/. , 1 995) .  APC 3' mutations 
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caused a lso hereditary desmoid disease (HOD) (Eccles et a/. ,  1 996; Scott et 
a/. , 1 996); an autosomal dominant predisposition characterized by multifocal 
desmoid tumors, one of the most clin ical ly relevant extracolonic 
manifestations of FAP (Samowitz et a/. , 1 995; Gismondi et a/. , 1 998). 
I n  1 977, a missense mutation in the APC gene was identified in 
Ashkenazi Jweish at codon 1 307. It was reported that 6% of the general 
Ashkenazi J ewish  population carried the APC 1 1 307 K mutation (Laken et a/. , 
1 977). I t  found out that the incidence of colon cancer in  the Jewish people 
more than those in non-Ashkenazi: Jewish population (Petrukhin et a/., 1 997; 
Abrahamson et aI. , 1 998). 
The pronision of genetic test is one of scientists concern to identify the 
cancer susceptibi lity genes to confinn the diagnosis of cancer syndrome in a 
patient. Several studies were done on using this test in person with h igh-risk 
and famil ies with a h istory of cancer (Petersen et a/. , 1 999; Glanz et a/. , 1 999; 
Bratt et a/. , 1 997;  Patenaude et a/. , 1 996; Lennan et al. , 1 995, 1 996a, 1 997). 
Lennan et al. ( 1 999) found that among fa mil ies with a known H N PCC 
mutation ,  only 43% of the at risk individuals elected testing to learn about their  
mutation status. 
In a study done by Karen et al. (2000) on the APC / 1 307 gene mutation 
associated with the increase risk of colorectal cancer in Ashkenazi Jews , they 
found out after analyzing the sex, age fami ly h istory and gene test, the 
association between 1 1 307K mutation and the risk of colon cancer. 
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Nugent et al. ( 1 994)  reported a study about variation in phenotypic 
expression in FAP, and they proved after comparing the phenotype of 27 
patients with deletion of 5 base pair in codon 1 309 with a group of 61  matched 
patients with FAP and seven d ifferent mutations. They found more colorectal 
polyps at the time of colectomy in the patients with 1 309 deletion (median 
number of polyps 4000 compared with 600) .  
Attenuated adenomatous polyposis coli (AAPC) or hereditary flat 
adenoma syndrome is a variant of FAP and phenotypical ly d ifferent from 
classical  F AP by the number of colon ic adenomas which is usually more than 
1 00.  These adenomas may have a flat rather than polypoid morphology 
(Lynch et aI. , 1 995). 
1 .6.2.2 A ttenuated Familial Adenoma Polyposis: 
AFAP is a heterogenous cl in ica l  entity and has less than 1 00 
synchronous or metachronous adenomatous polyps in the colorectum. In 
some patients AFAP is associated with APC mutations and also found in 
fami l ies with classic FAP ( Leppert et al. , 1 990; Spirio et al. , 1 993; BrenSinger 
et aI. , 1 998; Soravia et aI. , 1 998).  Other AFAP fami l ies do not related to APC 
mutat ions (Pedemonte et al. , 1 998). 
80th FAP and AFAP are associated with APC mutation . Most FAP 
pedigrees have mutations consistent with truncation mutations frameshift or 
nonsense primari ly in the first third of the gene (Miyoshi et al. , 1 992; Nagase 
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et al. , 1 992). AFAP i s  associated with truncating mutations pri mari ly in the 5' 
and 3' ends of the gene and possib ly missense mutations (Brensinger et al. , 
1 998). 
The common test to identifying APC mutation is performed with a 
proteins truncation test, which assays for the presence of foreshortened 
proteins generated by an invitro synthesized protein assay (Powel l  et al. , 
1 993) .  The sensitivity of th is test reaches up to 80% because mutations occur 
outside the codon reg ion not detectable even if it caused FAP. This test is 
avai lable and cost about $750. 
1 .6 .2.3 Hered itary Nonpolyposis Colorectal Cancer: 
Three to five percent of hereditary colon cancer is caused by hereditary 
nonpolyposis colorectal cancer (H NPCC). H N PCC is an autosomal dominant 
condition caused by mutation of one of several DNA mismatch repair genes. 
Unl ike sporadic cancer, H N PCC is associated with rig ht side colon cancer 
(Vasen et al. ,  1 99 1 ) .  Patients and their relatives are at risk of various cancers 
l ike endometrial adenocarcinoma, which affect one member at least in 50% of 
H N PCC pedigrees. Other possible neoplasms affecting H N PCC fami l ies are 
gastric, smal l  i ntestinal and ovarian adenocarcinoma and ureteral transitional 
and renal cell carcinoma (Vasen et a/. , 1 990; Watson and Lynch 1 993).  
1 .6.2.4 M ismatch Repair Genes: 
M ismatch repair genes are genes used to maintain the fidel ity of DNA 
during repl ication. If a mutation happen to these genes it wi l l  lead to HN PCC 
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(leach et aI. , 1 993; Papadopou los et at., 1 994; N icolaides et at., 1 994; Miyaki 
et aI. , 1 997) .  The genes that mutate in H N PCC include hMSH2 (human mut 
S homolog 2) on chromosome 2 p 1 6 ;  h MlH 1 (human mutl homolog 1 )  on 
chromosome 3 p2 1 ; h PMS1  and hPMS2 (human postmeiotic segregation 1 
and 2) on chromosomes 2q3 1 and 7q 1 1 ,  and h MSH6 on chromosome 2p1 6, 
but the most mutant genes that are responsible for HN PCC fami lies are 
thought to be hMSH2 and hMlH1  (Nystrom et at., 1 994) .  
1 .7 SYM PTOMS: 
A patient with colo recta I cancer suffers from symptoms depending on 
the s ite of  the tumor. I n  the caecum and right side of  the colon, the main 
complaint is of abdominal pain which maybe m istaken for gal l  bladder or 
peptic u lcer disease. The present feature is chronic iron deficiency anemia 
from occu lt b lood loss; frank melaena may occur with weight loss and 
episodes of diarrhoea (Minton and Martin , 1 978) , where as in  left side of colon 
is more infi l trating and cause obstructive symptoms due to the smal ler 
diameter and semisol id content, the change in  bowel habits ,  gasous pain ,  
bleeding and decrease in stool cal iber are the main symptoms of left side 
colon tumor (Mcsherry , 1 969) .  
1 .8 DETECTION: 
Patient with suspected colorectal mal ignancy go through many 
investigations to confirm the diagnosis ,  for that severa l ways are fol lowed 
starting with colonscopy, s igmoidoscopy, ultrasound and stool occult blood 
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test. A good screening test should recognize a symptomatic patients with 
high probabil ity from those with low probabil ity .  
1 .8. 1 ColoDscoPY: 
Colonscopy i s  sti l l  the best standard for screening,  biopsy and removal 
of clonic polyps, which can decrease the risk of colon cancer by 76-90% when 
removing polyps. Over 2 ,000, 000 colonscopies were performed in US in 1 994 
and over 650,000 of these underwent polypectomy (Kaster et al. , 1 995) 
Colonscopy can be used with or without barium enema depending on 
the detection lesions, but when they are used together they wi l l  g ive good 
diagnostic resolution. The use of barium enema can detect acute and severe 
i mflammatory bowel disease; suspected perforation and recent bowel wall 
biopsy (Margulis ,  1 969). Colonscopy have many l i mitations i ncluding fai lure 
to reach or examine fu l ly the splenic flexure ( 1 0%),  hepatic flexure ( 1 5%) and 
the cecum(20%) (Wolff, 1 975; Winawer, 1 976). 
1 .8.2 Sigmoidoscopy: 
In  the UK a tria l  has been proposed for screening the whole population 
from the age 55-60 years at least once (Atkins, 1 993). The same procedure 
is suggested currently by the American Cancer Society 
including dig ital recta l examination starting with the age of 40, and 
sigmoidoscopy every 3-5 years starting with the age of 50 for these who are 
known of high risk factors for colorecta l carcinoma, whereas this examination 
should be done very often for the high risk  people (Levin and Murphy 1 992). 
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It is estimated that 25-35% of polyps can be discovered with the rigid 
sigmoidoscopy, 50-55% with the 35-cm flexible scope and 65-75% with the 
60-cm scope (Ahlquist, 1 993).  
1.8.3 Ul trasound: 
Traditiona l u ltrasound is not very useful in the eva luation of colonic 
diseases, however, it can be quite of value when augmented by the 
retrograde insti l lation of water into the co lon (Limberg ,  1 992) .  Hydrocolonic 
sonography is  the scientific term for this procedure wh ich al low the evaluation 
of the structure of bowel wall (Pochaczevsky,  1 992). This technique can be 
usefu l in  staging for rectal cancer although it has some technical l imitations 
(Dershaw, 1 990; Sentovich , 1 993) .  
1.8.4 FecaJ Occult Blood Test 
The annual fecal occu lt blood testing can decrease the mortal i ty from 
colorecta l cancer by one-th ird (Mandel ,  1 993). 1 0% of those tested are found 
to have positive tests are from invasive cancer and 20-30% from adenomas 
(Hardcastle, 1 989). 
Fecal occult blood test (FOST) has been widely used for screening 
colorecta l cancer. The principle of this test is based on the act ivity of 
peroxidase l ike hemoglobin catalyzing the phenol ic oxidation of guaiac­
impregnated paper to a blue color. The hemoccult test is sensitive to at least 
twice the normal blood loss (approximate ly  4-6 ml of blood in 1 00 g of stool) .  
To avoid false result by hemoccu lt s l ides,  proper instructions regarding 
diet and medication should be g iven to the tested individuals and the test 
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should be performed proper/yo Food and med ication that g ive false positive 
results include red meat, turnips, broccol i ,  horseradish, iron supplement, and 
non steroidal anti-inflammatory medicines, they should be avoided 48hr prior 
to taking the test. To avoid negative result, ascorbic acid should be restricted 
during the test. 
Bleeding from the upper gastrointestinal or right side of the colon may 
be missed beca use of the increasing enzymatic d igestion and bacteria l  
degradation of the blood d uring prolonged transit time (Hardcastle et  a/., 
1 986). 
1 .8.5 Computerized Tomography and Magnetic Resonance Imaging: 
CT scanning is imperfect, but it is the best procedure for evaluating the 
l iver, abdominal cavity, and pelvis for metastases (Figure 6). CT or magnetic 
resonance imaging ( M R I) may be used to eva luate the area for lymph nodes 
and local extension. The sensitivity of CT and M R I  for detection involved 
pelvic nodes is only 35% to 40% ,  and these stud ies are associated with a high 
fa lse-negative rate (Rifkin and Wechsler, 1 986; Thoeni and Moss, 1 98 1 ; 
Thompson et a/. , 1 986). 
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1.8.6 Endoluminal Rectal U ltrasonography: 
Rectal ultrasonography is an accurate means of assessing the depth of 
penetration of the bowel wa l l ,  and can be used to verify or alter the cl inical 
impression formulated on the basis of digital examination (Nicholls et at. , 
1 982; Hi ldebrandt and Feife l ,  1 985). A 7.0-MHz transducer a llows separation 
of the tissue layers of the rectal wa l l  into five zones, representing five changes 
in  tissue density ,  which correlate to the interfaces between the d ifferent layers 
of the bowel wal l .  Cancers can be identified as being in the submucosa, in  
the muscu laris propria ,  or as fu l l-thickness lesions. Twenty seven of  30 
adenoca rcimas were correctly staged by  Zainea and co-workers using 
u ltrasonography (Zainea et at. ,  1 989). 
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Figure 6. Computed tomography (Cl) in the staging of colorectal ca ncer 
A, Pelvic Cl: An irregular rectal cancer is seen invading the peripheral 
structures (arrows). B, Abdominal Cl: liver metastases (arrows) stand 
out as hypodense lesions against the homogenous background of the 
liver parenchyma (Haskell, et 81. ,1995). 
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1 .9 PATHOLOGY: 
The main and majority of  colorecta l tumor neoplasms are 
adenocarcinomas besides other neoplasms. Lymphomas may arise 
from l ymphoid tissue within the gut and soft tissue sarcomas from 
mesodermal tissue tissue with in the gut (U l ich, 1 983). 
Also there are four other subcategories are defined. Mucinous 
or col loid adenocarcinomas which are characterized by abdundant 
extracel lular mucous production . I n  younger patients the most 
common adenocarcinomas is 'Signet ring' carcinoma wh ich are also 
mucin productive, usual ly in these kinds of tumors most of the mucin 
remains intracel lu lar ,  causing displacement of the nucleus and survival 
is very poor (Benello et a/. ,  1 980). 
Scirrhous tumors are marked by abundant dysplasia and a firm 
stricture l ike appearance on gross examination with very l ittle glandular 
formation.  
Tumors on the gross examination may appear to be fungating,  
u lcerating ,  or stenosing. The foremost type predominate in the right 
colon, whereas the latter most are seen more frequently in left colon 
(Bjeckeset et a/. , 1 987) .  
1 . 1 0  PROGNOSIS: 
The stage of the d isease is the most important factor in 
determining the prognosis for colorectal cancer patients. Beside 
staging ,  there are many histologic features of prognostic importance, 
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l ike tumor grade, whereas it is poorly moderately or well-differentiated 
tumors. Molecular abnormal ities may also estimate prognosis l ike p53 
tumor suppressor gene which is altered in most colorectal carcinomas,  
and the precise pattern of alteration may have prognostic value (Goh,  
1 994) .  
New immunohistolochemical techniques are being used to 
evaluate the presence or absence of staining for serotonin and 
carcinoembryon ic antigen (CEA) in  the prognoses of colorectal cancer 
(Arends et a/. , 1 986) .  The elevation of the C EA level correlate with the 
pathologica l  stage of the tumor (Sener et a I . ,  1 989). 
The gene for CEA is one of the most widely expressed genes in 
ca ncer cells (about 95% of colorectal cancer) (Goldenberg et aI. , 
1 976). Serum C EA protein recently is used to fol low the course of 
therapy in the management of colorectal cancer. The detection in the 
blood of tumor cel ls that express C EA could conceivably help in the 
prognosis of patients, fol lowing the cl in ical course of treatment 
(Guadagni et al. , 1 99n 
1 . 1 1 TR EATM ENT: 
1 . 1 1 . 1 Surgical Therapy: 
The main propose of surgical therapy is to excise the primary 
lesion cleanly adequate margins .  The various routes of spread must be 
considered, including lymphatic, i ntramura l ,  venous, and implantation 
(Haskel l ,  1 995). 
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1 . 1 1 .2 Radiation Therapy: 
Radiation therapy became an  efficacious way of colon cancer 
treatment when Rontgen rays and radium were d iscovered. The 
recommended doses for extrapelvic colon cancer include 4500 cGy at 
1 80-cGy fraction s izes to the tumor bed with a 4 to 5 cm margin .  A 
boost of 540 cGy may be given to the tumor bed with a l imited field.  
For patients with involvement of lymph nodes near the mesenteric 
l igation. the next level of unremoved lymph nodes may be irradiated .  
The aortic or i l iac nodes may be included if  the tumor was adherent to 
structures having primary lymph dra inage to these regions. 
The presence of various radiosensitive structures with in  the 
abdomen ma kes treatment p lanning complex. Exclusion of one or 
both kidneys and the majority of the l iver and l imitation of the dose to 
the spinal  cord are i mportant considerations. along with l imitation of the 
dose to the smal l  bowel .  
Therapeutic photon rad iation is sparsely ionizing and , therefore. 
can cause both lethal and sublethal damage to cel l .  Although the 
intracel lu lar targets are not precisely known , the DNA and supporting 
proteins are l ikely the main site of radiation damage. Radiation in 
therapeutic doses interferes with cel lu lar division . As a result ,  the 
desired or deleterious radiation effect is always delayed from the time 
of the actual exposure to the time of cel l  division.  
Acute radiation reactions occur during or immediately after a 
course of therapy. In the therapeutic dose range, this reaction is seen 
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only in tissue actively proliferating at the ti me of exposure. The 
res ponse in the gastrointestinal tract is  man ifested as increased 
secretions, mucosal inflammation , and edema. Flattening of the 
intestinal vi l l i  is seen microsco pical ly (Berthong , 1 986),  cli nically this 
leads to decreased transit time and d ianilea . The onset of clin ica l 
symptoms follows exposure by 7- 1 4  days and will persist for 7- 1 4  days 
after the last rad iation exposure. Acute injury tends to remain mucosal 
and superficia l .  The severity of these effects is dependent on the total 
duration of rad iation treatment, the dai ly dose, and the volume of tissue 
irradiated (Cox et a/. , 1 986) 
1 . 1 1 .3 Chemotherapy: 
Chemotherapy has been used in the pal l iation of colorectal 
cancer for more than 30 years, ever since the synthesis and investigation 
of the fluorinated pyrimid ines by Heidelberger in 1 950. 5-Fluorouracil 
(Fura, 5-FU )  was enthusiastical ly received at the outset, but recognition of 
its l imitations grew with increasing experience (Heidelberger et a I . , 1 957). 
1 . 1 2  INFLAMMATORY BOWEL DISEASE: 
I nflammatory bowel disease ( I BO) includes two d iseases, Crohn's 
d isease (CD) and u lcerative colitis (UC).  Both are lBO's and in their basic 
forms, are categorical ly d ifferent in their manifestations. They are g iven 
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common name because they sometimes resemble each other so closely that 
even a pathologist cannot d ist inguish between them ( indeterminate colitis) .  
Crohn's disease is characterized by inflammatory and connective 
tissue changes affecting a l l  layers of the bowel wall in both cel lular and 
extracel lular matrix components (Karl inger et a/. , 2000). 
Inflammatory bowel diseases occur world wide ,  they have a North­
South slope in their incidence, and a higher incidence of these d iseases can 
be observed in the Westernised or industrial ised areas of the world. Most 
references mention that the occurrence of I B D  is h igh in  North America and 
Northern and Western Europe, may be due to the common environmental 
factor (Loftus e( ' a/., 1 998). A racia l influence on the preva lence of both 
d iseases, in the same countries blacks are less affected than whites and the 
Jewish population is at highest risk everywhere due to genetic determination 
(N iv et a/. , 1 999). Dietary habit, smoking , hormones, d rugs beside the genetic 
background a l l  influence the causation of bowel diseases. 
Patients with long standing chronic ulcerative col itis are at increased 
risk for developing colonic epithel ial carcinoma (Lindberg et aI. , 1 996; Lashner 
et a/. , 1 989).  Colorectal cancer in  patients with u lcerative colitis usual ly 
occurs in s ites of inflammatory d isease and is normal ly preceded by 
dysplasia. Areas of bowel that do not manifest d isease, however, may sti l l  be 
sites of mal ignant transformation. The only way to prevent colorectal cancer 
in these patients is to resect the colon completely, which is a d rastic solution 
to the problem of increased risk, but is necessary when dysplasia is present. 
The alternative is  to create a rel iable means of early detection which 
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precancerous epithel ia l  dysplasia can be detected by colonoscopy (Leonard 
et al. , 1 983). 
The increase risk of colorectal cancer among patients with Crohn's 
disease is as high as 7-20 times . Cancer develops much earl ier in those with 
Crohn's d isease, occurring at a mean age of 48 years. Most of these cancers 
are located in  the right colon , and most are diffusely infi ltrating,  however, 
about one th ird of these cancers are found in normal mucosa, reflecting the 
fact that Crohn's d isease affects the entire gastrointestinal tract (Greenstein et 
al., 1 980) .  
1 . 1 3  A Descriptive study pattern of Colorectal Cancer in the United 
Arab Emirates : 
The United Arab E mirates in the last three decades has experienced rapid 
development in  many aspects of life and a l l  this have affected the preva lence and 
pattem of cancer. To our knowledge, there is only one study about the pattems of 
cancers in the UAE which was conducted in AI-Ain Hospital and publ ished 
(Thenaa et a l .  1 997) which included all the types of cancer cases in AI-Ain 
Hospita l for a period from 1 98 1  to 1 995. However, since colorectal cancer is 
h ighly influenced by environmental changes and including l ife style factors (E I-
Ghazawy et al . 200 1 ) ,  it is obvious that in the coming years col o recta I cancer will 
be one of the major cancer to be tackled in the Emirates.  
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CHAPTER II 
AIMS AND OBJECTIVES 
2.0 A I M S  AND OBJECT IVES 
2. 1 Aim: 
The aim of the present study to determine the germ l ine mutation of APC 
gene and its association with colorectal cancer and other d iseases and to 
describe the relationship between genetic and environment components of 
colorecta l diseases in UAE population. Thus this study aims at characterizing 
the environmental factors as wel l as the genotype , and a lso to estimate the 
relative occurrence of colorectal cancer in UAE and compare with other studies 
in Arabian Gulf and Western countries. 
2.2 Objectives: 
1 .  To apply a specifical ly designed questionnaire to case and control patient 
to col lect i nformation on their nature l ife style. 
2. To identify environmental risk factors associated with foods and drinks 
which result in some gastrointestinal disorders in affected people. 
3. To determine the germ-l ine mutation of APC gene of case and control 
subjects. 
4. To study the re lationship between the environmental and genetic factors 
in causing gastrointestinal d isorder includ ing cancer. 
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5. To compare the results and prevalence rate with avai lable studies from 
UAE and other Western Countries and developing countries . 
6. To study the epidemiology of colorecta l cancer in AI-Ain, UAE 
7. To present demographic data (age, sex and national ity) on colorectal 
cancer in UAE. 
8. To compare colorectal incidence with other national and international 
stud ies. 
45 
CHAPTER III 
MATERIALS AND METHODS 
3.0 MATE R IALS AND METHODS 
3. 1  Location:  
No study has  yet been conducted to define the epidemiology, 
environmental and genetic factors among case and control patient in  the 
UAE. The subj ects were selected from the Department of Preventive 
Medicine and AI-Ain hospital in AI-Ain city. 
3.2 Study Population and Details :  
Colorectal patient and non-colorectal patient were targeted to those 
who were attending the Preventive Medicine Department in AI-Ain and in  
colonoscopy department in AI-Ain Hospital . The study was conducted 
between June 2000- February 200 1 .  The purpose of this survey was 
explained to the patients with colorectal d isease and non-colorectal .  Those 
who agreed to participate were asked to sign the consent form and a 
questionnaire was appl ied to them through qua lified physicians, nurses 
and investigators. 
3 .3 Study Design : 
It is vital to obtain an accurate base for considering environmental 
influences on colorectal disease wh ich may lead to colon cancer. Th is study 
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was based on matched case-control study of colorectal patients and non­
colorectal subjects selected from AI-Ain city. This case-control study consisted 
of 65 cases and 65 controls. This study was conducted during a period 
between from June 2000- Februa ry 200 1 . 
Th is research study was performed by the following three steps: 
a) .  An epidemiologica l  study: Case-Control study. 
b) .  Laboratory ana lysis of whole blood DNA. 
c). A Descriptive study pattem of colorecta l cancer in the UAE. 
3.3. 1 An Epidemiological Study: 
I n  th is part of the study a brief questionnaire was used to collect 
information on socio-demographic characteristics of the target popu lation.  
The questionnai re was administered to colorectal d isease patient and non­
colorecta l d isease patient attending the Preventive Medicine Department 
in AI-Ain City and AI-Ain Hospital .  
3.3.2 Case - Control Study: 
Patients were classified as cases or controls according to the following 
criteria :  Case (colorectal disorder patient and seven colorectal cancer pateints) :  
Th is g roup consisted of 65 gastrOintestinal d isorder patient and those who 
suffered from a colorecta l problems. 
Controls: The 65 people were not colorectal patients and neither suffered 
from any gastrointestinal d isorder and were coming to the Preventive 
Medicine Department or employment health check up or for renewal 
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residency and routine check up. A specifical ly designed questionnai re was 
appl ied to the selected control people to el icit the required information on 
the fol lowing topics : 
a) .  Questionnaires about socio-demographic data 
b). Work history 
c) . Patterns of i l l-health and any information on medications taken 
d) .  Dietary habits and l ife style 
e) . The Symptoms occurring among case. 
Both cases and controls were drawn from the same geographic region for 
control l ing environmental and other geographical exposures. 
3.3.3 Laboratory analysis: 
3.3.3. 1 DNA Isolation:  
The DNA was purified from whole blood using QIAamp DNA Blood 
Min i  Kit (QIAG E N ,  Germany) . Two mi l l i l iter of venus blood sample was 
col lected in E DTA bottle and stored at 4° C for DNA purification or -20° C 
for subsequent analysis. 
Total DNA was purified by Q IAG E N  (Germany) according to 
manufacturer's protocol .  Briefly 20 J.l1 of Q IAG E N  protease was added to a 
1 . 5ml microcentrifuge tube and 200 J.l1 of the blood sample was added to 
protease solution. Two hundred microliters of lysis buffer (AL) was added 
to the sample and vortexed for 1 5  seconds. The samples were incubated 
at 56°C for 1 0  minutes and then briefly centrifuged at 8000 rpm. Two 
hundred microliters of 96% ethanol was added to the sample and mixed 
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again by vortexing for 1 5  seconds and briefly centrifuged. The previous 
mixture was appl ied in a QIAamp spin columns in a 2 ml col lecting tube 
and centrifuged for 1 minute at 8000 rpm. The QIAamp spin columns were 
placed in  a clean 2 ml col lecting tubes and the first fi ltrate was discarded . 
Five hundred microl iter of washing buffer (AW1 ) was added to the QIAamp 
spin columns without wetting the rims and centrifuged for 1 min with 
transfer of Q IAa mp columns to clean 2 ml col lection tubes. The next step 
was to add 500 11-1 of washing buffer (AW2) and centrifuged for 3 min . 
Final ly, the DNA was e luted from the columns into 1 .5ml tubes by adding 
200 11-1 of eluting buffer (AE) and centrifugation for 1 min. DNA quality was 
assayed on 1 % agarose gel in 1 X TBE ( 89 m M  Tris ,  89 mM borate, and 
2mM E DTA) . 
3.3.3.2 Polymeras Cha in Reaction: 
This analysis was carried out in  the research laboratory of Facu lty 
of Sciences - Biology Department, at the U .A. E .  University. Polymerase 
Chain Reaction (PCR) is an effective tool for amplification of selected 
reg ions of DNA molecu les . Regions of about 5-40 kb can be amplified 
effective ly. The appl ications of PCR technique is very widely used in 
molecular biology, especia l ly in DNA mapping,  DNA sequencing and 
phylogenetics; also it is being used in cl in ical diagnosis. 
PCR reaction consists of three major steps, namely, denateration, 
anneal ing, and extension. The target DNA is mixed with specific primers 
(forward primers and reverse primers) in the presence of deoxynucliotide 
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tri phosphate (dNTP), heat resistance DNA polymerase from thermophils 
(Taq Polymerase), and a ppropriate buffer in which Magnesium ions play a 
critical role.  I n  the first phase,  the target DNA is  denatured at 94°C, 
fo llowed by anneal ing at melting time T m specific for primers,  and 
extension at 72°C. Genera l ly, PCR reaction requires 30-40 cycles. 
In this study three systems of pri mers are used (Table 1 and 2 )  
depending on the frequencies of mutations obseNed in the APC gene, the 
forward primers and reverse primers (G IBCOBRL) were reconcentrated in 
TE buffer to the concentration of 0 .2 nmol/, .. d before used . A control 
experi ment was done to see the best condition and concentration for the 
experiments . Different concentration were used primers( 1 ,  2, 4 j..ll for each 
forward and reverse), 1 0  m M  dNTP (OA, 0 .8 , 1 .6 m M) ,  template (2.S,  S, 1 0  
j..ll ) ,  1 un iUj..l 1 enzyme ( 1 , 2 ,  4 unit) , SO m M  magnesium ions (0.8 ,  1 .6,  3 j..ll )  
and  Sj..l l buffer with 1 0X concentration. The best result was shown in 1 unit 
of enzyme and 3j..l1 of magnesium ions. 
A master m ix was done for 36 PCR tubes contain ing 1 0X Taq buffer 
with final  concentration 1 X, 1 0mM dNTP with final  concentration 0.8 m M ,  
2 .S  p mole/j..ll ,  SOmM magnesium ions, SuniUj..l1 Taq enzyme with final 
concentration 1 unit and deion ized water. Forty five microl iters of master 
mix was pipeted into PCR tubes adding Sj..ll of the templates in each tubes 
(total volume equal to fifty microl iters in each tube) ,  the tubes were 
vortexed and one drop of mineral o i l  was added before being placed in 
PCR apparatus. The result products were kept into 4°C. 
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Ta ble 1 .  The three systems for detecting mutations i n  the APC gene (Ando 
et al. , 1 993). 
System M utations Codon 
5-bp deletion 1 309 
(AAAGA) 
2 5-bp delation 1 06 1  
(ACAAA) 
3 5-bp delation 1 546 
(TGAAA) 
Size of PCR 
fragme nts (bp) 
(N) 9 1  
(M) 86 
(N) 75 
(M) 70 
(N) 1 1 6 
(M) 1 1 1  
Frequencies (%) 
1 7 .9 
8 .4 
1 . 1  
Ta ble 2.  Seq uences of primers used for PCR of three systems of mutation 
analyses in  the APC gene {Ando et al., 1 993}. 
Forward primers 
IC 1 GACACAGGAAGCAGA TICTG 
System 
1 
Reverse primers 
IC2 TICGCTCACAGGATCTICAG 
E9-4F A TGGGCAAGACCCAAACAC 2 E9-4R2 GT ACTTIGATTCCTIGA TIGTC 
E9-1 1 ACAGAAAGATGTGGAA TI AAG 3 I C 1 0  
3.3.3.3 Quantification of PCR Products: 
TTICTGCCTCTITCTCTIGG 
I n it ial ly al l  of the PCR products were quantified in 1 % Agarose in 1 X 
TBE. Appropriate amount of Agarose (GI BCOB R L) was mixed with 1 X  buffer. 
The mixture was placed in microwave oven for approximately 1 minutes, 
swirled occasional ly agarose was completely dissolved.  Forty microliter of 
Ethidium Bromide was added to the agarose solution and then poured in 
horizontal gel apparatus (GI BCOBR L). The PCR products (approximately 
5 1  
7j..l.1 )  were mixed with 1 X  loading dye and loaded onto the gel .  One hundred 
base pair ladder was used as a marker. 
3.3.3.4 Quantification of PCR Product on Polyacrylamide Gel: 
Specific PCR products were examined , the one which may have 
mutations from the three systems. Thirty percent (29: 1 )  acrylamide solution 
was prepared by adding 58g acrylamide with 2g bisacrylamide in 200ml 
deion ized water. Ten percent of Amonium persulfate (APS) was prepared by 
1 . 5g of APS to 1 5ml of deionized water, the solution was stored at 4°C. 
Polyacrylamide solution was prepared by mixing appropriate amount of 
acrylamide solution with 1 X TBE buffer and deionized water and subsequently 
TE M E D  (S I G MA) , and 1 0% of APS were added to the acrylamide solution. 
The solution was poured into vertical gel slab. 
3.4 A Descriptive Study Pattern of Colorectal Cancer in the UAE: 
3.4. 1 Population : 
This study was conducted in AI-Ain City, in the Abu Dhabi Emi rate. AI-Ain 
is situated in the Eastem part of Abu-Dhabi Emirate , which is the biggest emirate 
in terms of land mass and population. The population of UAE contains a large 
number of expatriates of d ifferent national ities. According to the recent Min istry of 
Health Annual Report, estimate showed that AI-Ain population is about 300,000. 
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3.4.2 Study Areas: 
There are two teaching hos pita ls in AI-Ain city, namely Tawam Hospital 
and AI-Ain Hospita l .  Tawam hospita l is recognized as a tert iary treatment center 
for cancer in the UAE. 
3.4.3 SUbjects: 
The retrospective study series consisted of 1 1 4 patients with colorectal 
carcinoma admitted to AI-Ain and Tawam Hospitals, the two teach ing hospitals in 
AI-Ain City, UAE between 1 985 to 1 998 [this data was original ly collected by Dr. 
I . M . H .  E I-Ghazawy ( EI-Ghazawy et al. ,  2000)] . There were 77 males and 37 
females with a malelfemale ratio of 2: 1 .  Their ages ranged from 1 3  to 85 years 
with a mean and standard deviation of 46.6 ±1 1 .8 years.  
3.4.4 Operative Data: 
The patients' fi les in  the surgery department were reviewed to obta in the 
fol lowing operative data : tumour subsite , type of operation: whether emergency 
or elective, type of resection, whether rad ical or pal l iative, lymph node 
involvement, intraperitoneal tumor spread and presence of l iver metastasis. 
3.4.5 l futoiogical Data :  
The cl in icopatholog ic parameters studied for prognostic va lue were age, 
gender, resection procedure, tumor size, depth invasion , nodal involvement, and 
d ifferentiation grade. 
The patients were followed for a period of with a mean and standard 
deviation of 30.89 ± 1 1 .72 months with a range of 6 and 1 20 months.  The dates 
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of cance r  specific death and local or d istant recurrence were recorded. 
Student t-test was used to ascertain the significance of d ifferences 
between mean values of two continuous variables. Analysis of survival curves 
were determined by the Kaplan-Meier Method, and differences in survival 
compared by the log rank test. Mul tivariate analysis by Cox model of proportional 
hazard was used to incorporate al l  the explanatory variables. Forward stepwise 
procedures and l ikel ihood ratios test were used to select independent variables 
with the greatest prognostic value .  
3.5 STATISTICAL M ETHODS AND ANA LYSIS 
3.5. 1 .  Data Processing: 
All  data variables were coded , processed and analyzed on the I B M  
computer o f  the Department of Community Medicine ,  Faculty of Medicine 
and Health Science at the United Arab Emi rates University. Data entry 
was performed using SPSS. The Statistical Software Package SPSS 
[Statistical Package for Social Science, Norusis,  1 996] ana lysis was used 
for performing all statistical analysis. 
3.5.2. Statistical Methods and Analysis: 
The Statistica l  Packages for Socia l Sciences [SPSS] , Norusis 
( 1 992) used for univariate and multivariate statistical analysis. Data are 
expressed as mean and standard deviation (SO) unless otherwise stated . 
Chi-square analysis was performed to test for d ifferences in the proportion 
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of categorica l variables between two or more groups . In 2 x 2 tables, the 
Fisher's exact test (two-tai led) replaced the chi-square test if the 
assumptions underlying chi-square were violated , namely in case of small 
sample s ize and where the expected frequency is less than 5 in  any of the 
cel ls. Student T-test was used to ascertain the Significance of differences 
between mean values of two continuous variables and confirmed by 
Mann-Whitney test non-parametric d istribution. Odds ratio (OR) and their 
95% confidence intervals (CI) was calculated by using Mantel-Haenzel 
test. The level p< 0 .05 was considered as the cut-off value for significance . 
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CHAPTER IV 
RESULTS 
4.0 RESULTS 
The study is presented as fol lows : 
4. 1 Epidemiological Data :  
There was significant difference between the two groups with 
respect to age (p =0.000) . Over 44 .6% of the colorectal patients are above 
40 years .  Table 1 .  Shows the characteristics of cases with colorectal 
condition and controls among the population surveyed.  As can be seen 
from this table the majority of colorectal patients were non-locals (96.9%) , 
where as the loca ls  were about 3 . 1 % .  There was n o  significant difference 
in national ity of both g roups (p =0.559). 
There were no significant differences between colorecta l patients and 
non-colorecta l patients with respect to level of education. Whi le the majority of 
colorecta l patient from the high level of education , (p  = .537), the non­
colorecta l patient sl ightly shifted towards a primary and secondary level of 
education as can be seen in (Table 1 ) . Also, with regard to marital status , the 
majority in both groups were married (76.9%) in case and (72 .3%) in control .  
The significant differences between the two groups were negl igible with 
respect to occupation (p= 0 .232), where as both show the highest present in 
manual  work 60% for the case and 63 . 1  % for control .  
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Table 2 .  g ives d ietary habit and l ife style among case and control .  Indian 
food and Arabic food were favored over Western food and the majority of 
both groups prefer the indian food 66.2% for case and 83. 1 % for contro l ,  
s ignificant differences were shown in food type (p= 0.027). Both case 
(95 .4%) and control (95 .4%) used vegetable oi l  more than other cooking 
oi ls. Also both don't prefer eating canned food 67.2% for case and 60% 
for control . 
The meal consumption da i ly, more than two in both groups and 
shows no sign ificant d ifference (p= 0.470). Whi le the number of times 
eating meat dai ly shows significant differences about 0.025 and mostly 
sh ifted towards one time dai ly in both groups , in contrast the amount of 
meat consumption weekly shows no significant d ifferences (p= 0. 1 25) and 
not going over 300 gram.  
Table 3. shows drinking habits among case and control patient. There was 
no significant d ifferences between case and contro l  patient in kind of ju ice 
used by them (p = 1 .00) and most of them d rink orange ju ice over the other 
kind of ju ices.  I n  contrast the dai ly cups consumed is s ignificant (p= 
0.037), most of the two g roups usual ly d rink one cup daily. Patients in 
both groups have high percent in dri nking acid ic drinks about 70.8% for 
case and 84.6% for control , were the number of cans drinking dai ly is 
significant (p= 0.039) and most of them drink at least one can da ily. Table 
3 a lso shows the alcohol habits in these patient where most of them don't 
drink alcohol (98. 5%) case and (93.8%) contro l .  
Table 4 .  g ives fru it and vegetable consumption among case and control . 
Patients often buy fru it and vegetable from specific emirate (AI-Ain)  and 
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that sign ificantly differs between the two groups (p= 0 .0 1 6) .  Case (75.4%) 
and control (87.7%) wi l l  eat fru it once dai ly and twice weekly, whi le eating 
vegetable most frequently dai ly and moderate weekly. Eating salad in 
moderate way daily and weekly in both groups. 
Table 5. shows water and mi lk  consumption among case and control . 
Most of them using Tap water as a source of drinking and they drink about 
one l i ter dai ly, while most patients don't l ike to drink mi lk, they are d rinking 
milk i n  l i tt le amounts about 1 /4 l iter dai ly 56.7% for case and 6 1 .5% for 
contro l .  
Table 6.  g ives the med ication taken by the patient, were few of them are 
suffering form gastrointestinal  disorder with significant difference about 
(p=0.04) ,  and few number of them are taking medication and dietary 
supplements. 
Table 7 .  Reported the physical activity among case and control .  
The majority of patient of the two groups don't make any exercise dai ly or 
wee kly (69 .2%) case and (73 .8%) contro l .  There was no Significant 
d ifferences between the two group in relation to physical activity. 
Table 9. show the symptoms among case and contro l .  
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4.2 Mutation Analysis: 
The set of primers designed for system 1 ampl ifies 91 bp flanking 
codon 1 309. It has been demonstrated that a common germ l ine mutation 
occurs in th is reg ion of DNA with incidence of approximately 1 7% Fami l ia l 
adenomatous polyposis fami l ies (Ando et aI. ,  1 993).  The mutation 
consists of 5 bp deletion (AAAGA) that is detectable on polyacrylamide 
gel .  I n  a l l  of mutational analysis ,  ampl ified DNA fragments were resolved 
on 1 % agrose for quantitative analysis. The fine resolution of DNA 
fragments were confi rmed on 8% polyacrylamide gel  for qual itative 
analysis. We have not detected the mutant al lele in a l l  of the subject 
groups involved in our study. However, a few other fragments, mainly high 
molecular weight DNA fragments , were also present; th is observation was 
not consistent between d ifferent PCR reaction batches. These high 
molecular weights DNA are l ikely due to non-specific ampl ification. On the 
other hand the lower molecu lar DNA fragments are due to abortive PCR 
reaction and are also not consistent from one to another sample. These 
observations ,  however, are not uncommon with PCR reactions and usual ly 
results from non-stringent anneal ing temperature .  It would have been 
profitable to i nvestigate this issue further, but because the size of the DNA 
and the nature of mutation are well documented, we have not attempted to 
characterize them beyond this pOint .  
Control and case subjects did not show differences in  the ampl ified 
reg ions. With regard to system 1 ,  20% of the samples showed one clear 
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major band . The rest of samples showed 2 to 3 bands and approximately 
1 0% demonstrate faint low molecular weight DNA fragments (Figure 1 ) . 
For system 2 that ampl ifies DNA fragment of APC gene flanking codon 
1 06 1 , results in a fragment of 75 bp for wild type. The mutant a l lele contains 
5 bp deletion (ACAAA). The majority of ampl ified samples consists of one 
andlor two bands (Figure 2 ) .  ( A  number of samples from case subjects have 
three bands, two major and one minor, while the colorecta l cancer samples 
showed one unclear minor band on the agrose gel . ) 
Primer specified for system 3 ampl ify APC gene flanking codon 1 546. 
Mutation in  this region of APC gene has implicated in approximately 1 . 1  % 
FAP family members .  This mutation results in  5 bp deletion (TGAAA). Most 
samples demonstrated low molecular weight DNA fragments corresponding to 
the expected DNA fragment. Samples from 1 -50 had one band (Figure 3) ,  
whi le the case samples had one to two. 
4.3 A Descriptive Study Pattern of Colorectal Cancer in the UA E: 
Duri ng the last twelve years a total 1 1 4 patients with colorectal cancer 
were d iagnosed and referred to Tawa m and AI-Ain hospitals in AI-Ain City, Abu 
Dhabi E mi rate ,  in UAE. Mean annual incidence was 1 2  patients 1 year. The 
overal l  i ncidence is 6.6 / 1 00 ,000 patients. There were 77 males (67.5%) and 37 
females (32 . 5%),  and total of national and Oman i  patients were 44 (38.6%) and 
non-UAE national were 70 (61 .4%) ( Figure 9 and 1 0) .  
The mean age at the time of d iagnosis is 46.6± 1 1 .8 years and with the 
median age of 47 years .  The distribution of cases according to age g roup is given 
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in Figure 1 1 .  The age of highest occurrence was between 41 -50 years and 
accounted for 34.2%, whi le the lowest accounted for 7.9 % of the patients were 
below the age of 30 years. 
The main presenting symptoms were abdominal pain (29. 1 %) ,  and change of 
bowel habits ( 1 5 .4%)  whi le the predominant sign was recta l bleeding ( 1 7. 2%) 
(Figure 1 2) .  
T h e  mean overa l l  survival t ime was 30.89 ± 1 1 .72 months with a range of 
6 and 1 20 months. The socio-demograph ic and cl inicopathologic characteristics 
of subjects is shown in Table 1 0  and 1 1 . The mean survival time was significantly 
shorter for patient aged 40 years or less (p<0.05).  Patients treated by pal l iative 
resection had a h ighly s ignificant shorter survival than patients who underwent 
potentia l ly curative surgery (p<0.001 ) . The mean survival time was significantly 
related to the lymph node status, peritoneal spread ,  l iver metastasis and Dukes' 
staging ( P<0.00 1 for each factor) . The mean surviva l time was also s ignificantly 
shorter for Patients with poorly d ifferentiated tumors than those with wel l  
d ifferentiated tumors (P<0.01 ) .  Although, patients with involved proxima l ,  d istal 
and/or lateral surgica l  margins showed a shorter mean survival time, this was of 
marginal  s ignificance. (P<0.05) .  
F igure 1 3  show the Kaplan-Meier survival curves for lymph node status. 
The pred ictor was s ign ificant as shown by the log rank test (p<0. 001 for lymph 
node positivity). In the Cox proportional hazards analysis presence of lymph 
nodes and Duke staging only were significant as shown by the hazard ratios . The 
hazard ratio for positive lymph nodes was 2 .50 (95% Confidence interval (CI)  
1 . 30 - 4.80) as compared to negative nodes and a hazard ratio of 0 .45 (95% CI  
0 .25-0.8 1 ) for Dukes stages A and B as compared to Stage C.  
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Figure 1 .  The frequency of bands in the DNA 
samples. 
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Figure 2. The frequency of bands in the DNA 
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Figure 3. The freq uency of bands in the DNA 
samples. 
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9 8 7 6 5 4 3 2 1 
Figure 4. Represents agrose gel 
electrophoresis of DNA fragment 
amplified by system 1 primer. 
Lane 1 ,  marker, lane 2-5, control 
lane 6-9, case. 
9 8 7 6 5  4 3 2 1  
Figure 5. Represents agrose gel 
electrophoresis of DNA fragment 
amplified by system 2 primer. 
Lane 1 ,  marker, lane 2-4, control 
lane 5-9, case. 
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9 8 7 6 5 4 3 2 1 
Figure 6. Represents agrose gel 
electrophoresis of DNA fragme nt 
amplified by system 3 primer. 
La ne 1 ,  marker, lane 24, control 
lane 5 -9, case. 
6 5 4 3 2 1 
Figure 7. Represents polyacrylamide 
gel e lectrophoresis of DNA fragme nt 
a mpl ified by system 3 primer. La ne 1 ,  
marker, lane 24, case, lane 5,6, control. 
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5 4 3 2 1 
Figure 8. Represents polyacrylamide 
gel electrophoresis of DNA fra gment 
a mpl ified by system 1 primer. La ne 1 ,  
marker, lane 2,3, ca ncer, lane 4,5, case . 
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Table 1 :  The chara cteristics of case and control a mong population 
surveyed 
Varia ble Case Control P-va l ue 
%=65( N )  %=65 (N )  significance 
Age groups 
< 30 1 3.8(9) 53.8(35) 
30-40 4 1 .5(27) 33.8(22) p<0 .000 1 
> 40 44.6(29) 1 2 . 3(8) 
Nationality 
UAE 3. 1 (2) 1 .5(1 ) NS 
Non-UAE 96.9(63) 98.5(64) 
Education 
I l l iterate 1 2 . 3(8) 9.2(6) 
Primary 27.7(1 8) 35.4(23) NS 
Secondary 29.2(1 9) 33.8(22) 
HighlUniversffy 30.8(20) 2 1 .5(1 4) 
Marital status 
Single 23. 1 ( 1 5) 27 .7( 1 8) NS 
Married 76.9(50) 72 . 3(47) 
Occupation 
Sedentary 23. 1 ( 1 5) 1 6 .9( 1 1 )  
Manual 64.2(43) 63. 1 (4 1 )  
Unski l led 7 .6(5) 1 5 .4( 1 0) NS 
Labour 
Ski l led Labour 3 . 1  (2) 4.6(3) 
NS = Not-Sign ificant 
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Table 2 :  Dietary habits and l ife style a mong case and control patient. 
Variable Case Control P-value 
%=65( N )  %=65( N )  significance 
Type of food 
Arabic food 33.8(22) 1 6.9(1 1 )  P=0.027 
Indian food 66.2(43) 83. 1 (54) 
Type of cooking oil 
used 
Vegetable oil 
Yes 95.4(62) 95 .4(62) NS 
No 4.6(3) 4.6(31 
Olive 
Yes 4.6(3) 1 . 5( 1 ) NS 
No 95.4(62) 98. 5(64) 
Ani mal  fatibutter 
Yes 1 0. 8(7) 20 .0( 1 3) NS 
No 89.2(58J 80.0(52) 
Eating canned food 
Yes 32.8(2 1 )  40.0(26) NS 
No 67.2(43) 60.0(39) 
No. of meals eating 
daily 
Two 7 .7J51 4.6J31 NS 
More than two 92.3(601 95.3(62) 
Buying fruit !vegetable 
from specific emirate 
Yes 87.7(57) 98.5(64) P=0.0 1 6  
No 1 2 . 3(8) 1 . 5 ( 1 ) 
No. of time eating meat 
daily 
None 1 3 .8(9) 1 .5(1)  
One 84 .6(55) 90.8(59) P=0.025 
More than one 1 . 5{1  7 .7151 
Amount of meat eating 
weekly 
200g 20.6(1 3) 1 5.6(1 0) 
300g 60.3(38) 76.6(49) 
400g 7. 9(5) 6.3(4) NS 
>500g 1 1 . 1 (7) 1 .6( 1 )  
NS = Not-Sign ificant 
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Table 3 :  Drinking habits and l ife style a mong case and control .  
Variable Case Control P-value 
%=65( N )  %=65( N )  significance 
Kind of juice 
Orange 
Yes 90.8(59) 90.8(59) NS 
No 9.216) 9.2(6) 
App le 
Yes 44.6(29) 49.2(32) NS 
No 55.4(36) 50.8(33) 
Carrot 
Yes 1 0. 8(7) 6.2(4) NS 
No 89.2(58) 93.8(61 ) 
Mango 
Yes 4.6(3) 0 .0(0) NS 
No 95.4(62) 1 00(65) 
Banana 
Yes 3. 1 (2) 0 .0(0) NS 
No 96.9(63) 1 00(65) 
Lemon 
Yes 6.2(4) 0.0(0) NS 
No 93.8(61 ) 1 00(65) 
No. of cup drinking 
daily 
None 1 5.4( 1 0) 1 .5 ( 1  ) 
One 73.8(48) 92.3(60) P=0.008 
More than one 1 0. 7(7) 6. 1 (4) 
Drinking acidic drinks 
(pepsi, Cokes, 7Up, . . .  ) 
Yes 70.8(46) 84.6(55) NS 
No 29.2(1 9) 1 5 .3(1 0) 
No. of cans drinking 
daily 
None 35.4(23) 1 3.8(9) 
One 60. 0(39) 78. 5(51 ) NS 
Two 6. 4 (3) 7 .7(5) 
Do you drink alcohol? 
Yes 1 .5 ( 1  ) 6.2(4) NS 
No 98.5(64) 93.8(61 ) 
NS = Not-Significant 
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Table 4 :  Fru it and vegetable consumption a mong case and control 
patient. 
Variable Case Control P-value 
%=65(N )  %=65( N)  significance 
No. of times eating fruit 
daily 
None 1 8 . 5(1 2) 3 . 1  (2) 
One 75.4(49) 87.7(57) P=0.0 1 7 
Two 6.2(4) 9 .2(6) 
No. of times eating fruit 
weekly 
None 1 .5(1 ) 0 .0(0) 
One 1 2 .3(8) 20 .0(1 3) 
Two 66.2(43) 63 . 1(4 1) NS 
Tree 4.6(3) 1 0.8(7) 
Four 9.2(6) 4.6(3) 
More than four 6.2(4) 1 .5(1 ) 
Frequently eating 
vegetable daily 
None 4.6(3) 0 .0(0) 
Seldom 3. 1 (2) 1 .5(1) NS 
Moderate 6 1 .5(40) 63. 1(4 1) 
Most frequently 30.8(20) 35 .4(23) 
Frequently eating 
vegetable weekly 
Seldom 6.2(4) 1 . 5( 1 ) 
Moderate 55.4(36) 56 .9l37} NS 
Most frequently 38.5(25) 4 1 . 5(27) 
Frequently eating salad 
daily 
None 6.2(4) 0 .0(0) 
Seldom 1 3 .8(9) 1 2 . 3(8) NS 
Moderate 73.8(48) 83. 1 (54) 
Most frequently 6.2(4) 4 .6(3) 
Frequently eating salad 
weekly 
None 4 .6(3) 0 .0(0) 
Seldom 9.2(6)  4 .6(3) P=0.047 
Moderate 70.8(46) 89 .2(58) 
Most frequently 1 5 .4(1 0) 6 .2(4) 
Spraying crops with 
pesticides 
Yes 1 3 .8 (9) 1 0 .8(7) NS 
No 86.2(65) 89 .2(58) 
NS = Not-Significant 
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Table 5 :  Water and milk consumption among case and control. 
Variable Case Control P-val ue 
%=65 (N)  %=65 (N)  Significa nce 
Source of water 
Tap water 83. 1 (54) 69.2(45) NS 
Bottled spring 1 6 .9( 1 1 ) 30.8(20) 
Amount of water drinking daily 
1 /2L 7 .7(5) 4 .6(3) 
1 L  66.2(43) 78. 5(51 ) NS 
> 1 L 26.2(1 7) 1 6. 9(1 1) 
No. of milk drinking daily 
1 /4L 56 . 7(34) 61 . 5(40) 
1 /2L 5 .0(3) 0 . 0(0) NS 
1 L  3 .3(2) 1 . 5 ( 1  ) 
Ni l  35 .0(2 1 ) 36.9(24l 
No. of milk drinking weekly 
1 /4L 1 0.8(7) 4 .6(3) 
1 /2L 4 1 . 5(27) 49.2(32) NS 
1 L  1 2 . 3(8) 1 0 .8(7) 
> 1 L  6 .2(4) 0 . 0(0) 
Ni l  29.2(1 9) 35.4(23) 
NS = Not-Significant 
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Table 6 :  Reported medication among case and control.  
Variable Ca se Control P-value 
%=65 ( N )  %=65 (N)  Significance 
Having any GI disorder 
Yes 24.6( 1 6) 6 .2(4) P=0.004 
No 75.4(49) 93.8(6 1 )  
Taking any medication 
Yes 1 0 .8(7) 4.6(3) NS 
No 89.2(58) 95 .4(62) 
Kind of medication 
Panadol 
Yes 1 .5 ( 1 )  0.0(0) NS 
No 98.5(64) 1 00(65) 
Zentic 
Yes 4.6(3) 0.0(0) NS 
No 95.4(62) 1 00(65) 
Flagyl 
Yes 1 .5 ( 1 ) 0 .0(0) NS 
No 98. 5(64) 1 00(65) 
Dulcolax 
Yes 1 .5 ( 1 )  1 .5( 1 )  NS 
No 98.5(64) 98.5(64) 
Moduretic 
Yes 3. 1 (2) 0 .0(0) NS 
No 96.9(63) 1 00(65) 
Antacid 
Yes 0.0(0) 1 .  5(  1 )  NS 
No 1 00(65) 98. 5(64) 
Taking any dietary 
suppliments 
Yes 3. 1 (2) 1 0 .8(7) NS 
No 96.9(63) 89.2(58) 
Kind of dietaf]1 suppliments 
MVT 
Yes 0.0(0) 9 .2(6) P=0. 0 1 2  
No 1 00(65) 90.8(59) 
Vit. C 
Yes 0. 0 (0) 1 .  5( 1 )  NS 
No 1 00(65) 98. 5(64) 
NS = Not-Significant 
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Table 7 :  Reported physical activity among case and control. 
Variable Case Control P-value 
%=65 (N )  %=65 ( N )  Significance 
Having any physical 
activity? 
Yes 30.8(20) 26.2( 1 7) NS 
No 69.2(451 73.81481 
How many times doing 
exercise weekly? 
None 66.2(43) 70.8(46) 
One 1 6.9(1 1)  1 6.9( 1 1 )  NS 
Two 7 .7(5) 9 .2(6) 
More than three 9 .2(61 3. 1 21 
NS = Not-Sign ificant 
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Table 8 :  Reported the number of family member who suffered from 
gastrointestinal d isorder among case and control. 
No. of Members Case Control P-va lue 
%=65 (N )  %=65 (N)  Significance 
How many member of 
the family suffer from g/ 
disorder? 
None 78.5(51) 95 .4(62) 
One 1 6.9( 1 1 )  4.6(3) P=0.0 1 3  
Two 4 .6(3) 0.0(0) 
NS = Not-Significant 
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Table 9 :  Reported symptoms among case and control.  
SYM PTOMS Case control Odds confidence P-va lue 
% =65 %=65 ratio interval Signf. 
Yes (N)  Yes ( N )  [OR] 
95% [CI] 
Blood in stool 1 8.5 (1 2 .0) 3 . 1 (2. 0) 1 .88 1 .40-2 .51  0 .01  
Anaemia 1 2 .3(8 .0) 0(0 .0) 2 . 1 4  1 . 77-2 .59 0 .006 
Abdominal pain 43. 1 (28.0) 4 .6(3 .0) 2 .42 1 . 83-3 .20 0 .000 1 
Weight loss 1 3. 1(9.0) 0(0 .0) 2 . 1 6  1 . 78-2 .62 0 .00 1  
Diarrhoea 2 1 . 5  (1 4 .0) 0(0.0) 2 .27 1 .85-2 .79 0 .0001 
Constipation 27.7( 1 8.0) 4 .6 (3 .0) 1 .99 1 . 50-2 .62 0 .000 1 
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61 .4% 
Fig 9 :  Distri bution of cases among national ity 
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Fig 10 : Distri bution of cases among nationa l ity 
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67.5% 
Fig 1 1 :  T he d istribution of cases according to age group 
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Table 1 0: The socio-demographic and cl inicopathologic characteristics 
of subjects - univa riate analysis 
Variable Frequency Percentage (%) 
( 1 ) Sex 
Male 77 67.5 
Female 37 32 .5  
(2 )  Age 
<40 1 2  1 0.5 
>40 1 02 89.5 
(3) Tumor site 
Rt.colen 38 33. 
Lt.colen 35 30.7 
Rectum 4 1  36 
(4) Type of operation 
E lective 82 72 
E mergency 1 8  28 
(5) Type of resection 
Curative 1 01 88.5 
Pall iative 1 3  1 1 .5 
(6) Lymph node 
Negative 42 36.8 
Positive 72 63.2 
(7) Peri toneal nodules 
Negative 87 76.3 
Positive 27 23.7 
(8) Liver Metastasis 
Negative 91  79.8 
Posi tive 23 20.2 
(9) Tumor type 
Adenocarcinoma 1 03 90.4 
Mucoid carcinoma 1 1  9 .6 
( 1 0) Tumor grade 
1 53 46.4 
2 5 1  44.7 
3 1 0  8 .8  
( 1 1 )  Duke's stage 
A 8 7 .0 
B 32 28. 1 
C 74 64.9 
( 1 2) Proximal & Distal 
Margins 
Negative 88 77. 1 
Positive 26 22.9 
( 1 3) Lateral Marg ins 
Negative 87 76. 3  
Positive 27 23.7 
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Table 1 1 :  The relationship between mean survival time and 
cl inicopathologic findings - univariate ana lysis. 
Va riable Frequency Percentage p-va lue 
( 1 ) Sex 
Male 4 1  63. 1 NS 
Female 24 36 .9 
(2) Age 
<40 7 1 0 .8  NS 
>40 58 89.2 
(3) Tumor s ite 
Rt .colen 27 4 1 . 5  
Lt.colen 20 30 . 8  NS 
Rectum 1 8  27 .7 
(4)  Type of operation 
E lective 47 72 .3  NS 
E mergency 1 8  27.7 
(5) Type of resection 
Curative 58 89.2 <0.00 1  
Pal l iative 7 1 0.8  
(6)  Lymph node 
Negative 6 1  95 <0.00 1  
Positive 4 5 
(7) Peritoneal nodu les 
Negative 55 85 <0.001 
Positive 1 0  1 5  
(8) Liver M etastasis 
Negative 62 4.6 <0 .001  
Positive 3 95.4 
(9) Tumor type 
Adenocarcinoma 60 92 .3  NS 
Mucoid carcinoma 5 7 .7 
( 1 0) Tumor grade 
1 26 40.0 
2 35 50.0 NS 
3 4 6 .7  
( 1 1 )  Duke's stage 
A+8 49 75 .3 <0.001  
C 1 6  24 .7 
( 1 2) Proximal & Distal 
Margins 
Negative 50 76 .9 <0.05 
Positive 1 5  23. 1  
( 1 3) Lateral Marg ins 
N egative 52 80 <0.01  
Positive 1 3  20 
NS= Not-significant 
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Table 1 2. Estimated c rude rate of ca ncer incidence by sex, and area (per 
1 00,000) (Abdul AI Aziz et a/., 1 995, Rasul et a/. , 2001 ). 
No. Area Male Female 
- -- - -
1 Eastern Africa 2 .4  1 . 9 
2 Northern Africa 4.2 3 .0 
3 Western Africa 5.9 6 .6 
4 Northern America 5 1 . 7  51 .7  
5 Japan 22 .2 1 8 .5  
6 Western Asia 5.6 5.6 
7 Eastern Europe 23.6 23 . 1  
8 Northern Europe 46. 7  48. 5  
9 Southern Europe 33. 8 30 .0 
1 0  Western Europe 49.2 I 49.6 
1 1  Austral ia 46. 3 46.2 
1 2  USSR 1 4 .0 1 7 .4 
1 3  Saudi Arabia 6.7 5 .9  
1 4  Qatar 8.7 6 .3 
1 5  UAE (Shamma, 4 . 1  3 . 1  
current study) 
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CHAPTER V 
DISCUSSION 
5.0 D I SC USSI ON 
5. 1 Epidemiologica l Data :  
The number of people suffering from inflammatory bowel d iseases 
have increased in the recent years.  I t  has a North-South slope in  incidence 
and lesser degree from West to East (Shivananda et a ! . ,  1 996) .  Nanj i  and 
Denard i  ( 1 986) reported that the incidence of bowel diseases in Asian 
countries is less due to lactose malabsorbtion,  they found out that the 
inflammatory bowel d iseases are rare where malabsorbtion is highly 
prevalent .  
U lcerative col itis can occur i n  a l l  ages and the highest incidence is in 
the 1 5-25 age g roup, with another peak in the 60s (Calkins and Mendeloff, 
1 986) .  I n  the present study, the people suffering from colorectal d iseases are 
the people who are above 30s. 
The highest incidence of inflammatory bowel d iseases is in the 
Westem countries. Different types of population are affected with d ifferent 
frequency. For example, in  the USA, b lacks and other races have a lower 
incidence than wh ite. This also occurs in South Africa and Brita in when 
investigating d ifferent immigrant populations (Niv et aI. ,  1 999). Beside race, 
d ietary behavior may have strong i nfluences on frequency of bowel d iseases. 
Studies have shown that natural feeding provides protection and any damage 
to the bowels in infants can lead to i nflammatory bowel d isease later 
(Whorwell et a I . ,  1 979 and Koletzko et aI . ,  1 989).  I n  the present study more 
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than 66% of colorectal patients were found to be be eating indian spicy food 
which can be an agent causing bowel d iseases. 
A case-control study examined the risk of U lcerative colitis in re lation to 
d ietary factors . The study included 1 0 1  patient with Ulcerative col itis ( 1 0-39 
years old) and 1 43 control subjects . The consumption of western foods was 
significantly related to an increased risk of Ulcerative colitis (trend, p=0.04). 
There was also a tendency toward positive association of bread for breakfast 
with Ulcerative colitis (trend= 0.07) .  As compared with l ife long non-smoker, 
current smokers tended to have a decrease risk of U lcerative colitis and 
former smokers and an increased risk (Epidemiology Group of Research 
Committee of I nfla mmatory Bowel Disease in Japan,  1 994) .  
Another case-control study h a s  been done b y  Russel and his colleague 
in 1 998 to investigate the possible pathogenic role of some characteristic 
'modem l ife' d ietary factors in inflammatory bowel d isease. In the study, 290 
patient with Crohn's d isease and 398 with Ulcerative col itis ,  compared with 
61 6 population controls. They found positive association with development of 
Crohn's disease because of Cola drinks [OR: 2.2 (95% CI 1 .5-3. 1 )] .  chewing 
gum [OR :  1 . 5 (95% CI 1 . 1 -2 . 1 )] and chocolate consumption [OR:  2 .5  (95% CI 
1 . 8-3 .5) ]  and negative association with citrus fru it consumption [OR : 0.5 (95% 
CI: 0 .3-0 .7)] and the development of Crohn's disease were found.  
Consumption of Cola drinks [OR :  1 .6 (95% C I  1 . 1 -2 . 3)] and chocolate 
consumption [OR :  2 .5 (95% CI 1 .8-3 . 5)] were positively associated with 
developing Ulcerative colitis ,  and there was a negative association between 
the intake of citrus fruits [OR: 0 .5  (95% CI 0 .4-0.8)] .  
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A series of 39 consecutive patients with Crohn's disease in clin ical 
remission were studied. Of these, 21 patients (Group 1 )  received oral 
nutritional supplementation , taken in add ition to their norma l diet. Relapsed 
rate , Crohn's disease activity index, and inflammatory markers were 
compared with that of 1 8  patients (Group2),  who were maintained on a normal 
unrestricted d iet over an observation period of 1 2  months.  The result cleared 
that total of 1 7  patient (81 %) tolerated the nutritiona l supplementation.  On an 
intention to treat basis, 1 0  patients (48%) patients in Group 1  rema ined in 
remission for 1 2  months, compared to 4/1 8 (22%) patients in Group2, 
(p<0.0003) .  Their  Crohn's disease activity index remained stable whi le their 
weight and body mass index improved during the period of nutrition therapy. 
Seven patients in Group1  and 1 4  in Group2 relapsed at a mean of 7.4+/-0 .9 
and 6.2+/-0.4  months, respectively. Four  patients ( 1 9%) were intolerant to 
enteral feeding .  The study concluded that, the nutritional supplementation is 
safe, we ll tolerated and effective in the long term management of patients with 
quiescent Crohn's d isease (Verma et at. , 2000) . 
Joachim (2000) created a database to capture the season of data 
collection,  d isease, food ,  and the subject's reaction to each food. He used 
1 22 item food l ist. Sixty patients with inflammatory bowel d isease (n = 33 
persons with Crohn's d isease , n = 27 persons with ulcerative colit is) 
completed the questionnaire about food and their reactions to the foods, the 
study identified foods that made the subjects feel better and worse. 
A very recent study done by Mahmud and Weir (2001 ) showed the 
relationship between the inflammatory bowel d isease and diet, where the 
incidence of Crohn's d isease is h igher in urban areas than in the rural 
85 
environment. Patients with Crohn's d isease have higher dietary intake of 
sucrose, refined carbohydrates omega-6 fatty acids,  and reduced intake of 
fruit and vegetables. 
Elemental exclusion d iets are known to be effective in Crohn's disease. 
However, patients relapse on returning to a normal diet, which suggests that 
there is something in an ordinary diet which on penetrating the mucosal defer 
mechanism of the terminal i leum, generates a pathogenic immune process. It 
has been suggested that the urban diet contains large quantities of inert 
inorganic non-nutrient microparticles such as natural  contaminants (soi l  and 
dust), food additives and anti-caking agents which may combine with 
intestinal luminal components such as bacterial cell wal l l ipopolysaccarides, to 
form antigen ic particles. When these are taken up by mucosal mononuclear 
ce l ls they can mediate immune reactions both loca l ly in the mucosa and in the 
systemic circulation.  They found that, the Cronhn's disease patients al located 
to a low microparticle diet experienced a significa nt reduction in Crohn's 
d isease activity and the requirement for corticosteroids, when compared with 
control group on normal d iet. The advantage of microparticle free d iet is i ts 
enhanced tolerance by the patient. 
One of the recent stud ies publ i shed on the influence of d iet on 
gastrointestinal d iseases is the study made by Pfaffenbach and Lux (200 1 ) 
and they d iscuss the benefit of d ietary measures in a number of 
gastroenterological d isorders. 
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I n  the current study the number of times eating meat is significa nt 
where most of the case patients eat meat once dai ly (84.6%). However, the 
dri nking habits from ju ice have negative association with the bowel d iseases. 
Despite the suggested benefits of exercise train ing in  the prevention 
and management of chronic d iseases , few data exist regarding the safety of 
exercise in Crohn's d isease and whether or not exercise may have beneficial 
effects on patient's health . A pi lot study was done by Loudon and his 
col leagues in 1 999 to eva luate the effects of regular l ight-intensity exercise on 
sedentary patients with Crohn's d isease. A twelve weeks wa lking program 
was supervised measuring the heart rate, the inflammatory bowel d isease 
stress index ,  the Harvey and Bradshaw s ipple i ndex, the Canadian Aerobic 
Fitness Test, and body mass index. Twelve subjects completed the 1 2-weeks 
exercise program. Subjects walked on average of 2 .9  sessionslweek at an 
average of 32 .6 min/session , and for an average distance of 3 .5  kmlsession. 
At the end of the study, statistically significant improvements were seen by al l  
measures with a trend toward reduction in  body mass index. Another study 
examined the effect of moderate physica l  exercise on gastrOintestinal function 
in a group of Crohn's d isease patients in remission. The result showed that 
exercise d id not el icit subjective symptoms or changes in intestinal 
permeabi l ity (D' i nca et aI. ,  1 999). 
I n  the present study most of the two group do not have physical 
activ ity, however, the rest who practice have no significant differences on 
bowel d isease. 
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5.2 M utational data: 
We have attempted to characterize the correlation between 
environmenta l factors and colorectal d iseases. This prel iminary study is the 
fi rst study that addresses the environmental correlation with colorectal cancer 
in the UAE population . In order to decipher the role of environmental factors, 
we have screened the population of this study for common mutations that are 
related to colorectal diseases, namely, cancer. APC gene was selected for its 
role in fami l ia l  cases of cancer. APC gene which contain 1 5  exons span on 
chromosome 5 in band q21 has been involved in colorectal cancer (Nagase et 
a/. , 1 992). Furthermore, total DNA extracted from whole blood was subjected 
for mutation analys is .  Therefore, mutation in the DNA extracted from blood 
represents germ l ine mutation and is inherited .  This phase of experiment wil l  
exclude colorectal d iseases that are the  result of d irect environmental insults 
or are the result of germ l ine mutation. I t  can be argued that colorectal 
d iseases with inherited pattern might a lso stem from environmental effect, 
however, such argument is not supported by the nature of economical and 
industrial  developments that are introduced in  the UAE. The UAE has 
recently undergone a drastic change in  a l l  major sectors and as result 
pol lution has increased only recently. Thus it is  l i kely that induced germ l ine 
mutation does not play any significant  role .  
We hypothesize that colorectal d iseases are the result of direct 
environmenta l effect on the pertinent tissues and does not evolve because of 
pre-existing germ l ine mutation . In our study, although it is prel iminary, we 
have not detected any variation in DNA sequence between the three groups 
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studied, namely, case, contro l ,  and cancer patients. Although a more 
elaborate screening that encompasses a larger region of APe might produce 
different results, we expect that findings are not l ikely for the regions screened 
covers the most frequent mutations report (Ando et a I . ,  1 993). The mutation 
detected for system 1 approaches 1 7% in the study conducted on pre­
symptomatic subject . On the other hand, mutations at other APe location do 
not exceed 1 -2%.  Al l of the subjects with colorectal d iseases screened for 
three different common mutations in APe did not exhibit any of the three 
mutations. 
It is  important to note that ,  this study screens for a gene associated 
only with a specific form of colorectal cancer and it does not represent all of 
colorecta l cancer. In addit ion, APe gene mutation has not been associated 
with colorectal d iseases. Although, we have not excluded the control or case 
groups from APe gene. Screening for it might play a role in the onset of 
tumorgenesis in  patients who are not diagnosed with colorectal cancer. 
Furthermore, we have screened a population for APe genes. 
I t  is important to note that th is study provides a prototype for other 
studies that might a im at addressing the correlation between environmental 
factors and colorectal disorders as it is important to exclude the hered itary 
forms of the colorecta l cancer. This study is l imited , nevertheless, for several 
major reasons: 1 )  the scope of this study does not al low the fu l l screening of 
the APe genes, 2)  the period al lowed for the study and subsequently the 
number of patients part icipating are not sufficient, 3)  the number of genes 
screened are not sufficient, and 4) most importantly the genes involved in 
most colorectal cancers have not been identified. 
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Further extensive research involving famil ies as wel l  as population 
based studies are required to del ineate the effect of environmental on 
colorecta l d iseases. Screening of the population for more known genes 
should form the comer stone of future studies to identify novel genes. The 
current study serves one such example as it has screened for common 
mutations in APC genes. A wide-genome search is another approach to 
identify colorectal d isease susceptibi l ity genes. It is becoming increasingly 
important the role of low penetrance genes in the onset of many d iseases 
includ ing cancers. These low penetrate genes are of polygenic nature and 
each individual variant contributes s l ightly to the development of the disease. 
Therefore, smal l ,  re latively homogenous, and inbred population is required to 
tackle polygen ic traits and the UAE population serves as the example of par 
excel lence .  
5.3 A Descriptive Study Pattern of Colorectal Cancer in the UAE: 
Our results show that younger patients have an earl ier recurrence and 
poorer surviva l as compared to older patients. These data are in agreement with 
several studies (Chapuis et a/. 1 985, Jass et al. 1 986, Bentzen et a/. 1 992 , 
Damhuis et al. 1 997, Fenandez et al. 2000) It is possible that young patients with 
colorectal cancer possess some genetic a lterations wh ich may be related to a 
more aggressive tumor behavior. 
Recently, some study showed that colorectal cancer is the leading cancer 
in Western countries,  over the last decades its trends have been general ly more 
favorable for women than men (Fernandez et at. 2000), th is is consistent with the 
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present study. 
Worldwide the incidence of colorectal cancer varies widely, i t  varies from 
1 . 7 cases per 1 00 ,000 I person I year in some west African countries to 51 .7 
case per 1 00,000 persons I year in Northern America (Table 1 1 ) .  There are very 
few studies form the Middle East countries (Western Asia 5.6) (Kathryn et aI. , 
1 98 1 ) .  A study from I raq in 1 984 showed an average estimate of incidence of 
colorecta l cancer as 3 .2 per 1 00 ,000 population (AI-Fouadi and Parkin,  1 984) .  In  
another study from Jordan, the incidence was 3.4 (Alkayed and H ijawi , 1 999). 
The low incidence of colorectal cancer in 6.6 per 1 00 ,000 I popu lation I year, may 
be due to many factors such as the type of diet, h igh fiber containing and excess 
fresh vegetable and fruits , high vitamins, low consumption of alcohol , and less 
people smoking. The high incidence of the d isease at a younger age group, 
below the age of 40 years was 1 0 .5%. the hig hest number seen in the l iterature, 
in the western stud ies ( 1 5%)  ( Kathryn et a/. , 1 98 1 ) . This could be due to the 
d ifferent pyramidal age d istribution in UAE population , the young people below 
age of 40 years constituting the majority of the UAE popu lation. In conclusion, 
this study shows that in colorecta l carcinoma the age of the highest occurrence is 
between 45-60 years which is simi lar to reports from Saudi Arabia ,  UK and Africa 
(AI-Shehri ,  1 996) and UAE (E I-Helal et a I . ,  1 997) .  The most common presenting 
symptoms was abdominal pain fol lowed by abdominal bleeding . The rectum and 
sigmoid was the common site of tumour and there is consistency between site 
and symptoms simi lar to other studies in USA and UK (Rosal in  1 992 , Emanuel 
and Farber 1 995, George 1 99 1 , Lawrence 1 998). Adenocarcd inoma grade I I  is 
the common h istopathological type, which is simi lar to other resu lts in  Saudi 
Arabia (AI-Shehri ,  1 996) and UAE (E I-Helal et a/. , 1 997 and E I-Ghazawy et aI. , 
9 1  
2001 ) .  There was no correlating between the histopathological type and 
prognosis. In the present study. most of the lesions were seen in Duke B and C 
whi le in Saudi Arabia Duke B and C was the common presentation. 
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CHAPTER VI 
CONCLUSION 
6.0 CONCLUSI O N  
UAE i s  one developing country that has undergone several 
changes in the past thirty years, as a result of these changes , many 
environmental problems which occur such as pol lution which can affect 
the health of the population . 
This study determined possible environmental factors 
associated with colorectal d isease that may develop to colorectal 
cancer. The questioner compares the l ife style and the nutritional habit 
between case and control .  There is evidence that some of a health 
problems are related to colorectal d isease such as anaemia ,  abdominal 
pa in ,  weight loss, diarrhoea and constipation. 
We th ink that these symptoms occur due to the pol lution in air, 
food , water, and wrong l ife habit wh ich lead to serious problems in the 
colon that may converted to colon adenoma. 
This study a lso concem in the genetic influence of the mutation 
in the formation of colorectal cancer. The study concentrate on 
screening the most frequent mutational reg ion in  the APe gene. The 
three screening systems did not show any difference in the mobil ity of 
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the DNA fragments ,  a lthough we d idn't detect any germ l ine mutations,  
further studies should be done in this area with large number of 
colorectal d isease and cancer patients and also more screening 
reg ions in  the APC gene. 
Finally, this study is the first study that addresses the 
environmental correlate with colorectal cancer in the UAE population 
and provide the basic information for other studies. 
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CHAPTER VII 
RECOMMENDATION 
7.0 R ECOMM E NDAT I O NS 
1 .  Screen more reg ions of the APC gene to detect the mutation 
involved in formation of colorecta l cancer. 
2. Screening the genes which may correlate in the formation of 
colorecta l cancer. 
3. Allow enough time to this study to screen more genes and more 
DNA fragment to detect mutations causing colorectal cancer. 
4. We strongly recommend more co-operation from the hospita ls 
and health centers to provide the study samples. 
5. Beside the DNA extraction from the blood samples, detect the 
DNA from the biopsy extracted from the colon may differentiate 
environmental mutations from the germl ine mutations. 
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Colon Cancer study in UAE population 
1. Study number: ___ _ 
2. Age:  ____ years 
3. Weight: _____ Kg 
4. H eight:  Cm 
A. Case r I 
5. Sex :  1 )  Male I 2) Female r ) 
B. Control r 
6. City: :  1 )  Abu Dabi [ I  2 )  Dubai [ J  3) AI Shari ka [ )  4 )  Ajman [ ]  5) AI-Ain [ 
5 )  AI  Fuj i rah [ I 6) Aum AI Qu iwen r ] 7 )  Ras AI Khama [ I 
7. Ed ucation : l )  l I I i terate[ ] 2 )  Primary r 3 )  Secondary [ ]  4 )  High/Univer. [ 
8. Ma rital status:  1 )  S ingle [ I 2 )  Ma rried [ ] 
9. Occu pation :  ________ ___ 
10.  What type of foods do you have usually: 
1 )  Arabic foods [ ) 2 )  Indian! Pakis. food [ ] 
1 1 . Do you use any of the fol lowing in  you r  cooking: 
1 )  Vegetable oil  [ ] 2 )  An imal fat I butter [ ] 
1 2 .  Do you usually eat canned food? I )Yes ( ] 
3 )  Western foods [ ] 
3 )  Olive oil  [ ] 
2 )  No [ ] 
1 3. Do you s p ray crops with chemical pesticides? 1 )  Yes [ ] 2 )  No [ ] 
1 4 .  How many meals do you usually eat daily? 
1 )  One [ ] 2 )  Two [ ] 3 )  Three [ ] 4 )  More than th ree [ 
1 5. Do you b uy fruit  and vegetable produced in any specific emi rates? 
1 )  Yes [ ] 2 )  No [ ] 
1 6. If yes from where? 
1 )  Abu Dabi [ ] 2 )  Dubai [ ] 3 )  AI  S hari ka [ J  4 )  Aj man [ ] 
5) AI Fuj i rah [ ]  6 )  Aum A I  Quiwen [ J  7 )  Ras AI  Khama r J 8 )  AI  - Ain [ 
1 7. W h at kind of ju ice do you usually d rink? 
1 )  Orange [ ) 2 )  Ap ple [ J  3) Ca rrot [ ) 4) Other: ____ _ 
1 8. How many cups do you usually d ri n k  dai ly? 
1 )  One [ ] 2 )  Two ( I 3 )  Th ree [ 4 )  More than three [ I 
19 .  How many times do you usually eat fruit in  the week? 
1 )  One [ I 2) Two [ I 3) Th ree ( 4 )  More than th ree [ I 
20. What  is the amount of fruit you usually eat ? ______ . __ _ 
2 1 .  How many times do you usually eat vegeta ble in the week: 
1 )  One [ I 2 )  Two ( ] 3 )  Th r'ee [ ] 4 )  More than three [ 
22.  Wh at is the amount of vegetable in  the week? 
------------------
23. Do you d rink acidic drinks ( Pepsi, Cokes, 7 up, . . .  eet) ? 
1 )  Yes [ I 2 )  No [ ] 
24. 1 8. How many cans  do you usually d rink dai ly? 
1 )  One ( I 2 )  Two [ I 3)  Three I I 
25. How many times you usually eat meat in the day? 
1 )  One I I 2 )  Two I I 3)  Three [ 
4 )  More than three ( I 
4)  More than three [ ] 
26. W hat is the amount of meat you usually eat? --------------------
27.  Source of d rinking water : 1 )  Tap water I I 
3)  Bottled spring water I ] 4 )  Bottle water I 
2)  Well water [ I 
28. What is the amount of water you usually dri n k  daily? 
1 ) 112 L. [ ] 
4 )  Two L. [ ] 
2)  One L. [ I 
5)M ore than two L. [ 
29. How many times you d rink mil k  weekly? 
1 )  One [ I 2)  Two [ ] 3 )  Three [ 
30. What is the amount of milk you usually d rink? 
1 )  One cu p [ I 2)  Two [ I 
3 1 .  Do you usually d rink alcohol ? 
3)  Three [ ] 
1 )  Yes [ I 
3 )  One and a half L. [ ] 
4 )  More than th ree [ I 
4)  More than three [ 
2 )  No [ I 
32. Do you h ave any gastrointestinal d isorder? 1 )  Yes [ ] 2 )  No [ I 
33. Do yo u take any med ication? 1 )  Yes [ I 2 )  No [ ] 
34. I f  yes what? __________________ __ 
35. Do you ta ke any d ietary supplemen ts ( Vitamins, . . ... ect)? 1 )  Yes [ 2 )  No [ ] 
36. I f  yes what? ____________________ _ 
37. Do you exercise? 1 )  Yes [ ] 2 )  No [ ] 
38. I f  yes how many times a week? 
1 )  One [ ] 2 )  Two [ ] 3 )  Three [ ] 4 )  More than th ree [ I 
39. Do you h ave the fol lowing sym ptoms / signs: 
1. Blood in stool 1 )  Yes [ ] 2 )  No [ ] 
2. A nemia 1 )  Yes ( ] 2 )  No [ ] 
3. A bdominal pain 1 )  Yes [ I 2 )  No [ ] 
4. Weight loss 1 )  Yes [ I 2)  No [ I 
5. Diarrhea 1 )  Yes [ I 2 )  No [ I 
40. H ow many member of the family suffer from gastrointestinal d isorder? 
1 )  One [ I 2 )  Two [ I 3) Th ree [ I 4 )  More than three [ 
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